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Background: Studies in rodents have found that high protein diets differ in obesogenic 
potential depending on the protein source used. Varied changes in morphology of brown 
adipose tissue, an important metabolic organ in mice and rats, have also been observed. 
Whether diversity in obesogenic potential of different protein sources is caused by amino acid 
composition, fatty acid composition or a combination of both is unknown. Further, little is 
known about causes and consequences of changes in brown adipose tissue morphology.  
Methods: Male C57BL/6J BomTac mice were fed different high-fat/high-protein diets. 
Casein, cod, pangasius and chicken was used as protein sources, but they also provided 
different amounts and types of fat to the diet. Pangasius, high in omega-6 fatty acids and with 
similar amino acid composition as cod, was used to distinguish between the effect of amino 
acid- and fatty acid composition. Four groups were fed ad libitum, and one group was fed 
restricted amounts of the chicken-based diet in order to evaluate the impact of weight gain on 
brown adipose tissue activity and morphology. We studied the effect of different protein 
sources on body weight development, energy intake, body composition, glucose homeostasis 
and gene expression in interscapular brown adipose tissue. Body composition was determined 
by MRI-scan and histology was carried out to examine changes in adipose tissue morphology. 
Insulin tolerance test and oral glucose tolerance test were performed to assess insulin 
sensitivity and glucose tolerance. Uncoupling protein-1 (UCP1) expression in brown adipose 
tissue (BAT) was analyzed by real time-qPCR and immunohistochemistry.  
Results: A high-fat/high-protein diet based on chicken was obesogenic relative to the one 
based on cod, whereas the pangasius-based diet had an intermediate effect. Calorie restriction 
attenuated changes in BAT morphology caused by the chicken-based diet. Similar classic 
BAT morphology as the one observed in lean chicken-fed mice was also observed in mice fed 
casein and pangasius. Little differences was observed in gene expression, but 
immunohistochemistry revealed higher expression of UCP1 in mice fed casein, pangasius and 
chicken in restricted amounts.      
Conclusion: Both amino acid- and fatty acid composition determines the obesogenic potential 
of different protein sources in high-fat/high-protein diets. Changes in BAT morphology and 
activity are partially decided by body weight, but pangasius as protein- and fat source 





1. 1 Overweight and obesity 
Overweight and obesity are one of the biggest health concerns worldwide. In 2014, about 39 
% of the world’s adult population (18 ≤ years) were overweight. This equals more than 1,9 
billion people. Of these, over 600 million, 13 % of the adult population, were obese (WHO 
2015). Alarmingly, the prevalence of obesity amongst children is also on the rise. Overweight 
among children under the age of five has increased from 4,8 % in 1990 to 6,1 % in 2014. The 
greatest increase has happened in low- and middle-income countries (WHO 2016).  
 
Overweight and obesity are defined as abnormal or excessive fat accumulation that may 
impair health (WHO 2015). Body weight index (BMI) is the most common measurement used 
to classify these conditions. The definition of BMI is a person’s weight (kg) divided by the 
persons square of height (m2). WHO’s definition of overweight and obesity are as follows 
(WHO 2015): 
- BMI ≤ 25 = overweight 
- BMI ≤ 30 = obesity class I 
- BMI ≤ 35 = obesity class II 
- BMI ≤ 40 = obesity class III 
It is important to notice that BMI is a valuable way of measuring overweight and obesity on 
population level. It is, however, an unsatisfying estimate on an individual level due to the lack 
of information on body composition and fat distribution (Bere 2011).   
 
1.1.1 Causes 
The causes of overweight and obesity are both intricate and diverse. A positive energy 
balance has traditionally been considered as the fundamental cause, which means that 
consumption of calories is in excess of calories used (WHO 2015). This may be caused by 
increased consumption, less physical activity or a combination of both. If this is the case, then 
the resolution to prevent and avoid overweight and obesity is a restricted calorie intake and/or 
increasing the physical activity level. However, this “calories in = calories out” theory is now 
under debate (Williams et al. 2015, Lucan and DiNicolantonio 2015). It may be that calories 
from fat, protein and carbohydrate have a different impact on weight gain (van Dam and 




is also a determining factor for developing overweight. Today’s increasing intake of 
processed food containing high amounts of salt, omega-6 fatty acids (FAs) and refined 
carbohydrates might lead to a less profitable composition (FAO 2013).   
 
A more sedentary lifestyle with less physical activity is also a factor contributing to the 
increased prevalence of overweight and obesity (WHO 2015), as well as genetic factors 
(O'Rahilly and Farooqi 2000). Novel research on gut microbes, microbiota, has highlighted 
yet another possible cause (Ley et al. 2006).  
 
1.1.2 Health consequences 
Overweight and obesity are associated with increased risk of a number of noncommunicable 
diseases:  
- Cardiovascular diseases (CVDs) such as hypertension, atherosclerosis, heart failure 
and stroke 
- Insulin resistance and type 2 diabetes 
- Some types of cancer 
- Osteoarthritis 
It may also have psychological consequences such as depression, body dissatisfaction, 
bulimia and low self-esteem (Kyrou, Randeva, and Weickert 2000).  
 
1.1.3 High protein- and high fat diets 
Fat is the most energy dense macronutrient (9 kcal/g), and so a low fat (LF) diet has 
traditionally been viewed as the best way of weight reduction and weight management 
(Helsedirektoratet 2014). The validity of the “calories in = calories out” theory is now under 
debate and as a result, diets that focus on macronutrient distribution rather than calorie intake 
has become increasingly popular. Intake of carbohydrates leads to insulin secretion and 
insulin induce lipogenesis and glycolysis. High fat (HF) diets, replacing carbohydrates with 
fat to reduce insulin secretion, is one way of changing the macronutrient distribution of the 
diet (Taubes 2010). Given the elevated diet-induced thermogenesis from protein (20 -30 %) 
compared to carbohydrates (5-10 %) and fat (0-3 %) (Tappy 1996), high protein (HP) diets 
have also gained more interest. HP diets are also thought to have a high satiating effect 




diets attenuates obesity in rodents. However, most of these studies uses diets based on milk 
protein such as whey or casein, whereas humans usually eats fish and meat as well (Liisberg, 
Myrmel, et al. 2016). Studies investigating the effect of HP diets in humans are not consistent 
(Te Morenga and Mann 2012, Halton and Hu 2004). Different protein sources may vary in 
obesogenic potential (Gilbert et al. 2011), and further investigation on the effect of different 
HP diets could therefore be of interest.   
 
1.2 Omega-6 and omega-3 essential fatty acids 
Omega-6 and omega-3 FAs are two classes of polyunsaturated fatty acids (PUFAs). The 
position of the first double bond, counting from the methyl end of the FA, is what generated 
the two names. In the n-6 and n-3 FAs, this bond is located at C-6 and C-3 respectively. The 
n-6 FA linoleic acid (LA, C18:2) and the n-3 FA α-linolenic acid (ALA, C18:3) are both 
essential fatty acids and crucial components of a healthy diet. However, the metabolism of LA 
and ALA to their higher unsaturated derivatives, arachidonic acid (AA, C20:4n6) and 
eicosapentaenoic acid (EPA, 20:5n3)/docosahexaenoic acid (DHA, 22:6n3), relies partially on 
the same enzymes (Figure 1.1). This leads to a competition between LA and ALA where high 
amounts of either FA might suppress the metabolism of the other. A balanced intake is 








Following synthesis, AA and EPA/DHA are included in tissue membranes, thus affecting the 
fluidity of the membranes. This will further influence the activities of membrane-bound 
proteins. Once incorporated in cell membranes, EPA and AA also act as substrates for 
eicosanoid synthesis. Eicosanoids are a family of signaling molecules that includes 
prostaglandins, thromboxanes, leukotrienes, endocannabenoids among others. In general, 
eicosanoids derived from AA endorse a pro-inflammatory state, whereas those synthesized 
from EPA countervail this effect (Harris 2006).   
 
1.2.1 Changes in consumption of omega-6 and omega-3 and possible consequences 
Today’s diet is widely different from our ancestor’s hunter-gatherer diet. Early man ate a diet 
based on uncultivated fruits and vegetables, seeds, nuts and wild game. The consumption of 
cereal grains where little to none. In today’s diet, cereal grains such as wheat, maize and rice 
account for a large amount of energy consumed (Simopoulos 2002). Furthermore, there is an 
increasing intake of vegetable oil such as soybean oil and canola oil. From year 1909-2000, 
consumption of vegetable-, salad- and cooking oils in the U.S. went from almost zero to near 
Figure 1.1 Metabolism of essential fatty acids. ALA and LA competes for the same enzymes 
towards the production of their 20- and 22-carbon derivatives. EPA and AA are precursors of 




18 kg per capita per year (Gerrior 2004). Additionally, wild game has been replaced with 
grain-fed livestock. One consequence of these changes is an increased intake of n-6 FAs and a 
change in the dietary n-6/n-3-ratio from ~1 to 15/1-16/1 (Simopoulos 2002).  
 
A high intake of LA might lead to a decreased tissue concentration of EPA and DHA. 
Furthermore, it may also engender increased concentrations of LA- and AA-phospholipids in 
cell membranes (Blasbalg et al. 2011, Alvheim et al. 2012). Considering the fact that n-6 
eicosanoids in general endorse inflammation, this may promote a prothrombotic and 
proaggregatory physiological state (Simopoulos 1999). Alvheim et.al (Alvheim et al. 2012) 
found that increasing dietary LA contributed to increased prevalence of obesity in mice. An 
increased consumption of LA, and the primary dietary sources of this FA, were also positively 
correlated with greater risk of obesity in humans. Further, the high intake of n-6 FAs in 
Western countries today is associated with the persistently high rate of CVD and the 
incidence of certain cancers (de Lorgeril and Salen 2012). 
 
The relationship between n-6 fatty acids, inflammation and CVD is, however, a matter of 
debate. A systematic review of 15 randomized controlled trials found virtually no evidence 
that an increased intake of LA leads to higher concentration of inflammatory markers 
(Johnson and Fritsche 2012). Harris et.al (Harris, Assaad, and Poston 2006) pooled data from 
case-control and prospective cohort studies, and found no evidence of adverse effects of n-6 
FAs on CVD.  
 
Due to these inconsistent results, the use of the n-6/n-3 ratio as a target for reducing 
inflammation and risk for CVD has been criticized (Harris 2006). There is evidence that an 
increased intake of n-3 FAs, which will give a lower n-6/n-3 ratio, will reduce the risk of 
CVD (FAO 2010). However, the evidence regarding the intake of n-6 intake and CVD are 
inconsistent, even though a reduction of n-6 FAs will have the same effect on the n-6/n-3 
ratio. It might be more expedient to focus on the absolute amounts of n-3 and n-6 FAs, rather 
than the ratio. For instance, the conversion of ALA to its higher unsaturated derivatives seems 






1.2.2 The endocannabinoid system 
The endocannabinoid system (ECS) consists of the endocannabinoids (ECs), the proteins 
catalyzing their biosynthesis and inactivation as well as the cannabinoid receptors. In the mid-
1960’s, the chemical structure of tetrahydrocannabinol, the major psychoactive component of 
the cannabis plant, were discovered. Further studies revealed that this component works by 
binding to specific plasma proteins and two cannabinoid receptor subtypes were identified: 
Cannabinoid receptor-1 (CB1) and cannabinoid receptor-2 (CB2). The discoveries of these 
receptors further led to the search for endogenous ligands, endocannabinoids, capable of 
activating them. Anandamide (N- arachidonoylethanolamine; AEA) was the first to be 
identified, followed by 2-AG (2-arachidonoylglycerol). These are still the most studied 
endocannabinoids and together with all others, they derive from AA-containing 
phospholipids. The ESC are thought to participate in a wide variety of responses, including 
control of food intake, energy expenditure, and glucose homeostasis (Matias and Di Marzo 
2007). CB1 is expressed in the brain, the gastrointestinal tract, skeletal muscle and adipose 
tissue, underlining the fact that the ESC regulates food intake and energy metabolism both at 
a central and peripheral level (Kim, Li, and Watkins 2011).  
 
As the endocannabinoids derives from a n-6 FA, it has been suggested that changes in the 
dietary n-6/n-3 ratio might affect ECS-activity (Simopoulos 2016). A study by Alvheim et al. 
(Alvheim et al. 2012) showed that increased amounts of LA in the diet led to increased AA 
content in red blood cell phospholipids. This was seen together with elevated levels of 2-AG 
and AEA in liver (Alvheim et al. 2012). Increased levels of endocannabinoids can further lead 
to increased appetite and food intake (Kirkham et al. 2002). Moreover, an increased intake of 
n-3 FAs seems to lower levels of AA in membrane phospholipids, thereby decreasing the 









1.3 The adipose tissue 
There are two different kinds of adipose tissue: White adipose tissue (WAT) and brown 
adipose tissue (BAT). These consist mainly of white adipocytes and brown adipocytes 
respectively. The white adipocytes serve as a lipid storage, whereas brown adipocytes are able 
to burn energy and produce heat (Cinti 2009). Therefore, obesity development may cause 
changes in the adipose tissue and changes in the adipose tissue may contribute to obesity 
development. 
 
1.3.1 White adipose tissue  
White adipocytes are the major component in WAT. These adipocytes are spherical cells 
containing a single lipid droplet (unilocular cells). Their size is mainly decided by the extent 
of this droplet, which constitutes >90% of the cell’s volume. The droplet serves as a storage 
of lipids in the form of triacylglycerols (TGs) (Cinti 2009). Traditionally, WAT has been 
considered only a storage of energy in the form of fat. However, it is now well established 
that white adipose tissue is an important endocrine organ, which synthetize and secrete a 
number of different cytokines, hormones, extracellular matrix proteins and vasoactive factors, 
all referred to as adipokines. Examples of adipokines are leptin, tumor necrosis factor-α 
(TNF-α), interleukin-6 (IL-6), etc. (Fruhbeck et al. 2001).  
 
1.3.2 Brown adipose tissue 
In contrast to the unilocular white adipocytes, brown adipocytes are multilocular cells 
containing several smaller lipid droplets. These cells also contains a considerable amount of 
mitochondria where uncoupling protein-1 (UCP1) is present. UCP1 is a mitochondrial protein 
that induces heat production, which is the main function of brown adipocytes. They can also 
act like a fat storage and endocrine cells, but to a lesser extent than that of white adipocytes 
(Rodriguez et al. 2015).  
 
UCP1 is a transmembrane protein located in the inner mitochondrial membrane. It creates a 
proton leak across this membrane, thus uncoupling adenosine-5'-trifosfat (ATP) synthesis 
from the oxidative phosphorylation, and heat is produced. This kind of heat production is 




thermogenesis in BAT. It releases norepinephrine, which binds to β-adrenergic receptors in 
brown adipocytes. This leads to activation of protein kinase A (PKA) via adenyl cyclase and 
conversion of ATP to cyclic-adenosine monophosphate (cAMP). PKA further activates 
triacylglycerol lipase by phosphorylation, which then cleave TGs into free fatty acids (FFAs). 
The FFAs override the inhibition on UCP1 caused by purine nucleotides leaving the protein 
active (Cannon and Nedergaard 2004). In rodents, non-shivering thermogenesis is activated 
when temperature drop below thermoneutrality (28-30 ⁰C) (Cinti 2009). 
 
In obese animals, the characteristics of the brown adipocytes gradually change to be more like 
those of white adipocytes. The many small lipid droplets merge into larger ones and the 
number of mitochondria declines (Cinti 2009).   
 
1.3.3 Beige adipocytes – a third type of fat cell 
The major white and brown fat depots are located at anatomically different positions, but as 
early as the 1980’s it was reported that multilocular UCP1-expressing cells could be found 
within the white adipose tissue after cold exposure (Young, Arch, and Ashwell 1984, Loncar, 
Afzelius, and Cannon 1988). These cells have later been named beige or “brite” (brown in 
white) adipocytes. The beige adipocytes are similar to white adipocytes when unstimulated, 
but cold exposure leads to a change in UCP1 expression making the cells more similar to 
brown adipocytes. When stimulated, UCP1 expression and non-shivering thermogenesis in 
beige adipocytes could equal that of brown adipocytes (Peirce, Carobbio, and Vidal-Puig 
2014). Studies investigating brite adipocytes have demonstrated that these cells have 
distinctive gene expression signature, leading to the suggestion that beige adipocytes are a 
distinct type of fat cells (Wu et al. 2012). 
 
Brown adipocytes derives from the same Myf5+precursor cell lineage as skeletal muscle cells 
(Figure 1.2). Transcriptional regulator PRDM16 plays a critical role in the fat/skeletal muscle 
switch. Binding of this transcriptional regulator to transcription factor PPAR-γ induces 
differentiation into brown adipocytes in lieu of myocytes (Seale et al. 2008). The cold induced 
co-activator PGC-1α is also an important regulator of BAT development and function. 





1.3.4 Origin of adipocytes 
Until recently, it has been approved that white adipocytes are derived from Myf5- precursor 
cells only (Wu, Cohen, and Spiegelman 2013). However, this view was recently challenged 
by Sanchez-Gurmaches et al. (Sanchez-Gurmaches et al. 2012), who discovered the presence 
of some Myf5+ adipocyte precursors in WAT. Beige adipocytes can derive from white 
adipocyte precursors, which means that they most likely shares the same Myf5- lineage of 
origin (Wu et al. 2012). It seems like different types of white adipocyte precursors may have a 
different potential to produce beige adipocytes and that some also are distinct beige precursors 
(Peirce, Carobbio, and Vidal-Puig 2014).  Additionally, studies have indicated that the beige 
adipocytes can originate directly from mature white adipocytes (Rosenwald et al. 2013, 
Himms-Hagen et al. 2000) (figure 1.2). However, other studies have found conflicting results 
(Wang et al. 2013), leaving this interconversion from white to beige an unresolved question.  
 
Figure 1.2 Origins of adipocytes. Origin of brown, white and beige adipocytes. Brown adipocytes 
originates from at Myf5+ lineage, whereas white and beige originates from Myf5- precursors. They 
may also derive from the same Myf5+ lineage as brown adipocytes. Figure is adapted from (Peirce, 




The determination of phenotype during adipogenesis seems to involve both transcriptional 
factors, co-activators and miRNAs as well as epigenetics. PPAR-γ along with its co-activators 
PGC-1α, SRC1 and PRDM16 appears to promote brown/beige adipogenesis. PGC-1α is an 
important regulator of the expression of thermogenic genes in brown adipocytes, but it is also 
an essential regulator of various processes in other cells and organs. Per contra, PRDM16 
seem to be more specific at inducing the expression of these genes.    
 
1.3.5 Brown adipose tissue as a target of obesity prevention  
BAT is found in mammalians only (Cannon and Nedergaard 2004). In most rodents, it is 
located both subcutaneously (interscapular, axillary and cervical) and visceral (mediastinal 
and perirenal) (Cinti 2009). It is also well known that human infants have relatively large 
active interscapular depots of BAT. In human adults on the other hand, BAT has been thought 
to be nonfunctional and with no significant physiological relevance (Cannon and Nedergaard 
2004). However, recent studies have confirmed that this is not the case (Virtanen et al. 2009, 
Cypess et al. 2009). This knowledge, combined with the new evidence of beige adipocytes, 
has revealed a new target of obesity prevention. Both increased activation of existing BAT 
and induced formation of beige adipocytes in WAT could potentially inhibit excessive weight 
gain and development of  metabolic syndrome (Peirce, Carobbio, and Vidal-Puig 2014, 
















1.4 Introduction to the study 
Given the fact that overweight and obesity are on the rise worldwide, weight reduction and 
weight regulation is a highly relevant topic. In order to maintain a healthy weight, Norwegian 
Health Authorities recommend a diet consisting of 45-60 % of energy (E%) from 
carbohydrates, 25-40 E% from fat and 10-20 E% from protein (Helsedirektoratet 2014). 
Whether this is the most optimal distribution of macronutrients, is now under debate. In recent 
years, diets with a higher proportion of protein and/or fat, has gained increased interest as 
methods of weight reduction and weight management. However, studies have shown that HP 
diets differ in obesogenic potential, depending on the protein source used. Tastesen et al. 
found that mice fed casein and cod/scallop remains lean, whereas mice receiving chicken 
develop obesity (Tastesen, Ronnevik, et al. 2014). In another study carried out by our research 
group, mice were fed HP diets with either casein, soy, cod, beef, chicken or pork as protein 
source (Liisberg, Myrmel, et al. 2016). This study showed that casein stands out as the most 
efficient protein source in preventing weight gain. Mice fed cod and beef protein had an 
increased body weight gain compared to the mice fed casein, but to a lesser extent than mice 
fed pork or chicken. The diets based on chicken and pork were highly obesogenic, even more 
so than a high fat/high sucrose control diet. Furthermore, mice fed the HP casein diet 
maintained a classic morphology in their interscapular BAT (iBAT), whereas brown 
adipocytes in mice fed pork and chicken had a morphology much more like white adipocytes, 
with fewer and larger lipid droplets.  
 
Of notice, these protein sources varies in endogenous fat composition. Cod contains higher 
levels of n-3 FAs compared to chicken and pork, which are higher in the n-6 FAs. It is known 
that n-3 FAs, especially when they originate from phospholipids, can have an anti-obesity 
effect (Alvheim et al. 2012, Rossmeisl et al. 2012, Liisberg, Fauske, et al. 2016). Therefore, 
the differences in obesogenic potential of these HP diets may be a consequence of a different 
amino acid composition, a different fatty acid composition or a combination of the two.  








1.5 Aims of the study 
In this study, pangasius (Pangasianodon hypophthalmus), an Asian shark catfish, was 
introduced as a new protein source. The amino acid composition of pangasius is similar to cod 
(table A.2, appendix I) and the fatty acid composition is similar to chicken (table A.4, 
appendix I). Feeding one group pangasius, as well as having a chicken- and a cod-fed group, 
could therefore give the opportunity to distinguish between the effect of the amino acid- and 
the fatty acid composition. Furthermore, one group received a restricted amount of the 
chicken-diet. The goal of this restriction was to keep the mice lean and investigate whether 
the change in iBAT morphology in mice fed chicken is caused by the protein source itself, or 
rather a consequence of obesity. Given that changes in iBAT morphology may affect 
thermogenesis and energy expenditure, we also wanted to assess expression of genes involved 
in metabolic processes in this tissue.  
 
To summarize, the aims of this study were as following: 
- To investigate whether differences in the amounts of n-3 and n-6 FAs may contribute 
to the varied obesogenic potential of different HP diets 
- To evaluate the effect of different protein sources on glucose homeostasis 
- To study if the “whitening” effect of chicken as a protein source on iBAT morphology 
is caused by the protein source itself, or rather a consequence of obesity 














2.0 Materials and methods 
2.1 The animal experiment 
The mice used in this experiment were C57BL/6J BomTac mice (figure 2.1). This mouse 
model was chosen due to its ability to develop obesity, hyperglycemia and hyperinsulinemia 
when fed a HF diet (Black et al. 1998, Surwit et al. 1988). Eighty male mice were bought 
from Taconic Europe (Ejby, Denmark) at a weight of approximately 25 g. Upon arrival, the 
mice had a seven-day acclimatization period, during which a body scan was performed. 
Seventy of the mice was then divided into seven groups (n=10) based on body weight, lean 
mass and fat mass. Each group received a different diet. Two of the groups were reference 
groups, receiving either a LF or a high fat/high sugar (HF/HS) diet. The remaining five groups 
received high fat/high protein (HF/HP) diets containing four different protein sources: Casein, 
cod, pangasius or chicken. The reference groups and four of the HF/HP groups were fed ad 
libitum, whereas the last group was given a restricted amount of the HF/HP chicken-based 


















Figure 2.1 Private photo of a C57BL/6J 




2.1.1 Ethical statement 
This animal experiment were approved by the Norwegian Animal Health Authorities (ID 
nuber FOTS: 5358). No harmful effects were observed during the trial. 
 
2.1.2 Diets 
The four experimental HF/HP-diets, containing ~ 41 g protein and ~24,5 g fat /100 g, were 
produced at NIFES. Reference diets were a pre-bought LF diet (Ssniff Spezialdiäten GmbH, 
Germany) and a HF/HS diet (Ssniff Spezialdiäten GmbH, Germany). 
 
 
One group received casein as their protein source, one cod, one pangasius and two groups 
received chicken (figure 2.2). The first six groups were fed ad libitum, whereas the last group 
was given a restricted amount of the chicken-based diet. The objective of this restriction was 
to keep the mice at the same weight as the mice in the casein-fed group. After two weeks of 
experimental feeding, the amount of feed given to the restricted chicken group was reduced 
by 38 % compared to the other groups. The amount of feed given was further reduced later on 
(table 2.1), as the mice in this group gained more weight than the individuals in the casein-
group despite feed restriction.    
 
Week Feed given (g/day) Restriction* (%) 
2 2 38 
3 1,8 44 
6 1,65 49 
9 1,6 51 
                *all other HF/HP-groups recieved 3,25 g feed/day 
Table 2.1 Amount of feed given to the restricted chicken- fed group. 





2.1.3 Preparation of the diets 
The chicken (Solvinge renskåret kyllingfilet, Rema 1000), cod (Fiskemannen, Rema 1000) 
and pangasius (Godehav skinn- og benfri filet, Polar Seafood Denmark, Rema 1000) were 
warm-treated, freeze-dried and homogenized at NIFES. All ingredients were weighted on a 
Mettler Toledo PG42002-S/PH weight, mixed in a Crypto Peerless EF20 blender and then 
stored at -20 ⁰C. Diet composition are displayed in table A.1 in appendix I along with AA- 
and FA- composition of the diets (table A.3 and A.5 respectively). 
 
2.1.4 Housing and feeding 
The mice were single caged (Tecniplast 1291) and kept in a termoneutral room (28-30 ⁰C). 
The room had a 12-hour light/dark cycle. Each cage was equipped with wooden bedding, 
nesting material, a house and a chewing stick. Feeding was carried out three times a week; 
Monday, Wednesday and Friday. Total feed intake was measured during the entire 
experiment by weighing the feed before feeding as well as weighing the remains that were left 
when the mouse was given a new meal. When changing cages, the bedding in the old cages 
was shifted and feed residue was collected and weighted. Changing of cages took place every 
second week. The water bottles were changed once a week. 
 
2.1.5 Measurements 
Once a week, all the mice were weighted on a Mettler Toledo (PG42002-S/PH) weight. A 
body scan was performed at baseline and after nine weeks. The scan was conducted using a 
Bruker Minispec LF50mq 7.5 magnetic resonance imaging (MRI) apparatus. This apparatus 
uses a magnetic field to distinguish between fat mass, lean mass and free water, thus giving 
information on the animal’s body-composition.  
In week nine, the wooden bedding in the cages was replaced with a paper cover. In the end of 
the week, all feces were collected. The feces was analyzed for fat and nitrogen content and 
this was further used to calculate apparent nitrogen- and fat digestibility. Technicians at 
NIFES analyzed fat and nitrogen content as described in (Tastesen, Ronnevik, et al. 2014). 






2.1.6 Insulin tolerance test 
An insulin tolerance test (ITT) was conducted after ten weeks of experimental feeding. Prior 
to testing, the mice were transferred to a clean cage containing wooden bedding and their 
house. The mice were in a randomly fed state. Each mouse was injected intraperitoneally with 
insulin (1.00 U/kg lean mass). A small slit was made to puncture the tail vein, and blood 
glucose was measured with a glucometer (Contour, Bayer) at baseline and 15, 30, 45 and 60 
minutes after injection. After testing, all tails were sterilized with 70% ethanol (EtOH) in 
order to prevent infection.    
 
2.1.7 Oral glucose tolerance test 
After eleven weeks, an oral glucose tolerance test (OGTT) was performed. Five hours before 
testing, the mice were weighted and moved to clean cages equipped with wooden bedding and 
their house. After a five hour fasting period and a new weighting, a small incision to puncture 
the lateral tail vein was made. Blood glucose was measured with a glucometer (Contour, 
Bayer) and 20 μl blood was collected in an EDTA coated minivette and transferred to an 
eppendorf tube. An oral dose of glucose (3 mg/g lean mass) was given. Blood glucose was 
measured 15, 30, 60 and 120 minutes after glucose administration. 20 µl blood was also 
collected after 15 and 30 minutes. All collected blood was centrifuged at 1000 x g for 5 
minutes at 4⁰C, 7 µl plasma was collected and subsequently stored at - 80⁰C for further 




Upon termination, all mice were weighted. Termination was executed in a randomly fed state. 
The mice were anesthetized with isofluran (Isoba-vet, Schering Plough, Denmark) by putting 




was performed by cardiac puncture. Blood from the heart was collected with a syringe 
connected to a tube containing an EDTA anticoagulant. The samples were then centrifuged at 
2500 x g at 4⁰C for five minutes. Plasma and red blood cells were stored separately at -80 ⁰C 
for further analysis.  
Four different adipose tissues were dissected at the termination point: Retroperitoneal white 
adipose tissue (rWAT), epididymal white adipose tissue (eWAT), inguinal white adipose 
tissue (iWAT) and interscapular brown adipose tissue (iBAT), the first two being visceral 
adipose tissues whereas the two latter is subcutaneous. Additionally, the liver, kidneys and 
intestine were excised, as well as one muscle: m. Tibialis anterior. Samples for histology were 
collected and fixated in 4 % formaldehyde. Tissues for qPCR or other testing were snap 
frozen in liquid nitrogen and stored at -80 ⁰C. Duodenum, jejunum, ileum and colon were also 




Samples from liver, iBAT, eWAT and iWAT were placed in a plastic cassette at termination 
and fixated in 4% formaldehyde in 0,1 M phosphate buffer (PB) overnight. The samples were 
then transferred to 0,1 M PB and stored at 4 ⁰C upon the following dehydration. 
 
2.2.2 Dehydration and paraffin infiltration 
To remove fixation solutes and water from the tissue sections, the PB was replaced with 
gradually increasing concentration of alcohol (Table A.6, appendix II). When the tissues were 
completely dehydrated in 100 % alcohol, the alcohol was replaced with xylene. This is a 
medium soluble in both alcohol and paraffin. Paraffin (Histolab, Sweden) was then heated to 
59 ⁰C in a transportable heater and the samples were placed in the paraffin overnight to remove 
the xylene. 
 
2.2.3 Embedding in paraffin 
Prior to embedding, the paraffin was replaced once to remove traces of xylene (Table A.6, 
appendix II). The samples were then embedded using a EC 350 Paraffin embedding center 




bottom of a metal mold. After removing the top of the plastic cassette, the tissue samples were 
placed in the mold and fastened by leaving it on the cold component for a short while. The 
bed of the cassette was placed over the mold, and this was filled with paraffin and left on the 
cold board until completely stiffen. The block of paraffin was then removed from the mold. 
 
2.2.4 Sectioning and staining  
Prior to staining, the samples were sectioned at Molecular Imaging Center at Haukeland 
University Hospital. The slides were 5μm thick. A rehydration was then performed, followed 
by a staining with hematoxylin and eosin (H&E). The procedure was executed in a ventilation 
chamber. Time schedule and solutions are listed in table A.7, appendix II. Hematoxylin stains 
the nucleus of the cells, whereas eosin adds color to the cytoplasm. After staining, the slides 




Immunohistochemistry was performed in order to investigate the presence of UCP1 in iBAT, 
and differences between the experimental groups. 
 
Upon the immunohistochemistry process, rehydration was necessary to make the tissues more 
reactive (table A.8, appendix III). The different steps of the immunohistochemistry are listed in 
table A.9 in appendix III along with content of the different reagents and solutions. Citrate 
buffer was heated in a water bath, and was used in order to make the epitopes more available. 
Between each treatment, phosphate-buffer saline (PBS) was used to wash the slides. To avoid 
oxidation by peroxidases, H2O2 in methanol (MetOH) was applied. Incubation with goat serum 
was necessary in order to avoid background staining. The primary antibody binds to the epitope 
on the UCP1-protein, whereas the secondary antibody binds to the primary. Avidin-biotin-
peroxidase-complex (ABC) binds to the secondary antibody. Further, diaminobenzidin 
tetrahydrochloride (DAB) was applied. ABC oxidizes DAB, causing precipitation and a 
coloring of the antigen-antibody-complex. Finally, the nuclei were colored with hematoxylin 
and dehydration (table A.8, appendix II) was performed. The slides were mounted with a water-





2.2.6 Microscopy   
Inspection of cell morphology of iBAT and iWAT, as well as UCP1 expression of iBAT, was 
carried out using an Olympus BX 51 binocular microscope. A representative field from each 
tissue section was photographed with an Olympus DP50 3.0 camera. Adipozyte size was 
determined by Adiposoft (Galarraga et al. 2012). UCP1 expression was quantified by ImageJ. 
 
2.3 Ultra Sensitive Mouse ELISA Insulin Kit 
The Ultra Sensitive Mouse Insulin ELISA Kit (Crystal Chem Inc., USA) is a kit for the 
quantitative determination of insulin in mouse serum, plasma and fluid. This kit was used to 
measure insulin levels in plasma collected at the start of the OGTT-test and 15 minutes after 
glucose distribution. Reagents are listed in table A.10 in appendix IV. Method was performed 
according to the protocol given by the manufacturer.   
 
Prior to assay procedure, a preparation of working mouse insulin standards was necessary. 
150 μl of sample diluent and 50 μl of mouse insulin stock solution (25,6 ng/ml) was mixed in 
a microtube, giving the mix an insulin concentration of 6,4 ng/ml. Sample diluent was also 
added to seven more tubes, 50 μl in each. 50 μl of the 6,4 ng/ml standard was then added to 
the first tube containing only sample diluent. This was mixed thoroughly and 50 μl was then 
added to the second tube and so on (figure 2.3)  
 
In a microplate containing 96 anti-insulin antibody-coated wells, 95 μl of sample diluent was 
added to each well. 5 μl of each sample and the insulin standards was then distributed on the 
plate, which was further incubated for 2 hours at 4⁰C. This allowed for insulin in the samples 
to bind to the guinea pig anti-insulin antibody coated on the microplate wells. Following 
incubation, unbound material was removed by washing the wells with wash buffer. The 




washing was performed using an automatic plate washer (1296-026 Delfia Platewash). A 
second reaction was then carried out by adding 100 μl of anti insulin enzyme conjugate in 
each well. The plate was then incubated at room temperature for 30 minutes, followed by a 
new washing. In this second reaction, horse radish peroxidase (POD)-conjugated insulin 
antibody is bound to the guinea pig anti-insulin antibody/mouse insulin complex. Immediately 
after the second washing, 100 μl of enzyme substrate solution (TMB) was dispersed in each 
well and reacted for 40 minutes in room temperature. In this third reaction, the bound POD-
conjugate reacts with the clear TMB-solution, converting it to a colored product. The reaction 
was stopped by adding 100 μl per well of enzyme stop solution. Conclusively, absorbance at 
450 and 660 nm was measured with a spectrophotometric plate reader (VictorX5, Perkin 
Elmer) and the results were calculated. 
 
2.4 Reverse Transcription qPCR 
A reverse transcription (RT) quantitative real-time polymerase chain reaction (qPCR) was 
carried out to identify relative gene expression of several brown markers in iBAT. Upon the 
qPCR, RNA-purification and -precipitation were necessary, as well as measuring RNA 
integrity and doing a reverse transcription from RNA to cDNA.  
 
2.4.1 Homogenization and RNA-purification  
Agencourt RNAdvance Tissue Kit (Beckman Coulter, USA) was used to retrieve purified 
RNA from iBAT. Reagents and prepared solutions are listed in table A.11 in appendix V. 
First, tissue samples were homogenized. The samples were transferred to tubes containing 2 
zinconium beads and 630 μl lysis buffer and homogenized using a Precellys 24 lysis & 
homogenization instrument (Bertin Technologies, France) at 5500 rpm for 2 x 30 seconds. 
The tubes were then spun down and incubated at 37 ⁰C for 25 minutes. Further, two 12 000 x 
g centrifugations at 4⁰C were carried out. Following the first and second centrifugation, the 
aqueous phase were transferred to a new tube. 400 μl binding buffer was then added to the 
lysate and a 5 minute incubation followed. The tubes were further incubated for 6 minutes on 
a magnetic rack, the supernatant was removed and the tubes were removed from the magnetic 
rack. 800 μl wash buffer was added and a 5 minutes incubation on the magnetic rack 
followed. Further, supernatant was removed, the tubes were removed from the magnetic rack 




carried out, followed by removal of the supernatant and two more ethanol-washes on magnet 
with a 2 minutes incubation in between. After the last ethanol-wash was carried out, the tubes 
were removed from the magnetic rack and left to dry for 10 minutes. Finally, 40 μl MQ-water 
was added and samples were incubated for 2 minutes before being moved to the magnetic 
rack and given a final 8-minute incubation. The eluate was transferred to a new tube and RNA 
concentration was measured with Nanodrop ND-1000 spectrophotometer (Saveen Werner, 
Sweden). The measurement with the Nanodrop also gives information regarding sample 
quality by measuring absorbance and calculating the A260/A280- and A260/A230-ratios.   
 
2.4.2 RNA-precipitation 
As measurements made with the Nanodrop spectrophotometer revealed unsatisfying 260/230-
ratios, RNA-precipitation was necessary. 100 μl ice-cold ethanol and 4 μl 3M NaAc (pH 5,2) 
was added to each sample, and they were further stored at -80 ⁰C overnight. Precipitation was 
carried out by spinning the samples in a centrifuge at 12 000 x g at 4 ⁰C for 20 minutes. 
Supernatant was removed and 1 ml ice-cold 75% EtOH was added. After a 5 minutes 
centrifugation, supernatant was removed once more and 15 μl water was added. The 
Nanodrop ND-1000 was used to measure concentration and ratios. 
 
2.4.3 Measuring RNA integrity, Bioanalyzer 
RNA integrity was measured using Agilent 2100 Bioanalyzer (Agilent Thechnologies, USA) 
and an RNA 6000 Nano LabChip kit (Agilent Technologies, Germany). Each RNA chip 
contains an interconnected set of microchannels. In the BioAnalyzer, nucleic acid fragments 
are driven through the channels by electrophoresis and separated based on their different 
sizes.  
 
Upon procedure, RNA dye concentrate was equilibrated to room temperature. The concentrate 
was then vortexed and spun down before 0,5 μl was added to a tube containing 32,5 μl RNA 
gel matrix. Further, centrifugation (10 min, 13 000 x g, room temperature) was needed before 
placing the chip in the priming station and pipetting 9 μl gel-dye mix in the well marked G. 
The plunger was positioned at 1 ml and the chip priming station was closed. After 30 seconds, 
the plunger was released. 9 μl of gel-dye mix was added to two more wells, and 5 μl of RNA 




1 μl of the samples distributed in the twelve sample-wells. Twelve randomly selected samples 
were used. Finally, the chip was placed in the Agilent 2100 Bioanalyzer. Two chips, 
containing in total 24 samples, were measured.         
 
2.4.4 Reverse transcription reaction 
To convert the single stranded RNA to double stranded cDNA, a RT reaction was performed. 
All samples were individually diluted to a concentration of 50 ≤ ± 3% ng/μl. The Nanodrop 
spectrophotometer was used to measure concentrations.  Further, to make a standard curve, 2 
μl from 35 of the samples were pooled in a new tube. Concentration was measured and a 100 
μl solution with the concentration of 100 ng/μl was prepared. A double dilution was carried 
out, resulting in six solutions with decreasing concentrations (Figure 2.4).      
 
 
A RT-reaction mix was prepared (table A.12, appendix V). Two negative controls were 
included, a non- amplification control (without multiscribe enzyme, NAC) and a non-template 
control (without RNA, NTC). To a 96-well RT-plate 40 μl RT-reaction mix was added to all 
wells (except the NAC-well). Further, 10 μl of each RNA-sample was distributed on the plate. 
Water was added to the NTC-well. A clean plate cover was put on and the plate was 
centrifuged (50 G, 1 min, room temperature). Conclusively, a Gene AMP PCR System 9700 
PCR machine (Applied biosystems) was used for the RT-reaction. The program is presented 
in appendix V, table A.13. Upon qPCR, the plate was stored at -20 ⁰C.  




2.4.5 Quantitative real time polymerase chain reaction  
To quantify gene expression in iBAT, qPCR was conducted. Volume of the cDNA plate was 
doubled by adding 50 μl ddH2O in each well. Further, the cDNA plate was centrifuged (1000 
x g, 1 minute) and vortexed (1300 rpm, 5 minutes). Real time PCR mix was made according 
to table 2.2 and distributed to an eight-well strip (112 μl/well). Primer names and sequences 
are presented in table A.14, appendix V. Pipetting was carried out by robot (Biomek® NXP 
Laboratory Automation Workstation, Beckman Coulter USA), adding 2 μl of sample cDNA 
and 8 μl PCR mix to a 384-wells Real Time plate. The plate was further covered with an 
adhesive optical cover and centrifuged for 2 minutes at 1500 x g. qPCR was performed using 
a Light Cycler 480 instrument (Roche Diagnostics). Due to group variations in housekeeping 
genes measured, cp-value was used to calculate amounts of mRNA and relative gene 
expression.   
 
 
2.5 Statistical analysis 
Processing of raw data was carried out in Microsoft Excel 2013. GraphPad Prism 6 was used 
to identify outliers by Grubb’s test. Normality was determined by D’Agostino-Pearsons test 
and equality of group variances stated by Brown-Forsythes test. GraphPad was also used to 
perform a one-way analysis of variance (ANOVA) with Fisher’s LSD multiple comparisons 
post hoc test. Growth, feed intake as well as data from ITT and OGTT were analyzed by 
repeated-measurements (RM) ANOVA with Fisher’s LSD. Finally, as the normality 
assumption of a one-way ANOVA was not met, Kruskal-Wallis test was performed on data 
on apparent fat absorption. The reference groups were excluded from the statistical analysis, 
but are shown as scattered lines. All data are presented as mean ± SEM. Group means were 
considered statistically different at p ≤ 0.05 and differences are marked by different letters. 
Reagent Volume (μl) 
ddH2O 330,6 
Primer (forward) 5,7 
Primer (reverse) 5,7 
SYBR Green PCR Master Mix 570 
 





The different experimental diets varied in obesogenic effect and lead to differences in body 
weight development as well as in body composition. Observations made throughout the 
animal experiment, including body weight development, energy intake and changes in insulin 
sensitivity and glucose tolerance will be presented in the first three sections. The last sections 
focuses on observations made post termination, such as changes in adipocyte size and 
morphology as well as differences in gene expression. Body weight gain and energy intake 
are presented up to week nine of the experiment due to the possible impact of ITT and OGTT, 
conducted in week ten and eleven respectively, on feeding behavior. In order to differentiate 
the calorie restricted chicken-fed group from the one fed ad libitum, this group are referred to 
as the “chicken (restricted)-group”. 
 
 
3.1 Body weight development and body composition 
3.1.1 Body weight development 
Different HP diets had a different effect on body weight development, as presented in figure 
3.1. A HF/HP diet based on chicken, pangasius and cod were obesogenic relative to a casein-
based diet. After nine weeks the pangasius-fed mice had a greater body weight gain than the 
group fed cod. Furthermore, there was a trend towards higher weight gain in the group fed 
chicken compared to the pangasius fed-group (p = 0.095). Analysis with RM ANOVA (figure 
3.1 A) underlines this. The mice fed casein had the lowest weight gain, although not 






3.1.2 Body composition 
To further investigate if weigh gain was due to an increased amount of fat mass or lean mass, 
an MRI-scan was performed at the beginning of the experiment and after nine weeks. Results 
from MRI-scan at week nine are displayed in figure 3.2. The higher weight gain observed in 
the chicken-fed group is mainly due to increase in fat mass (figure 3.2 A, D). Furthermore, 
when pangasius was used as protein source, the mice gained more fat than those fed cod, but 
less than those fed chicken (figure 3.2 B). In contrast to other groups, mice in the group fed 
casein had a slight decrease in fat mass. In this group, weight gain was mainly due to 
increased lean mass (figure 3.2 D). Interestingly, when chicken was used as protein source 
instead of cod or casein, the mice gained less lean mass (figure 3.2 D). This did not seem to 
be a consequence of weight gain, as similar results was observed in the chicken (restricted)-
group. Pangasius as protein source had an intermediate effect (figure 3.2 C-D).  
Figure 3.1 Body weight development and total weight gain. Body weight development (A) and total 
weight gain (B) after nine weeks. Body weight development was analyzed by RM ANOVA. Total body 
weight gain was analyzed using a one-way ANOVA with multiple comparison (uncorrected Fisher’s LSD) 
of the mean of each experimental group. Results are presented as mean ± SEM. Statistical differences (p 
≤ 0.05) are marked by different letters. 
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Figure 3.2 Body composition. MRI-scan was used to detect changes in body composition. Total fat 
mass (A), change in fat mass relative to baseline (B), total lean mass (C) and change in lean mass 
relative to baseline (D). Group variations were analyzed using a one-way ANOVA with multiple 
comparison (uncorrected Fisher’s LSD) of the mean of each experimental group. Results are presented 




3.2 Energy intake, feed efficiency and digestibility 
Throughout the entire experiment, feed given as well as remains were weighted to monitor 
each mouse’s total feed intake. This was used to calculate total energy intake and investigate 
if the differences in weight gain were caused by differences in energy intake.  
 
Figure 3.3 B reveals that mice fed casein, the group with the lowest body weight, had the 
highest energy intake as well as the chicken-fed mice. Further, mice fed chicken ate more than 
mice fed cod. The group fed pangasius had an intermediate energy intake compared to these 
two. RM-ANOVA analysis is in the affirmative (figure 3.3 A).  
 
Based on energy intake, weight- and fat mass gain, feed efficiency was calculated (figure 3.3 
C-D). Chicken as protein source had significantly higher feed efficiency compared to casein 
or cod. The casein-based diet had lower feed efficiency than all other groups, whereas the 
pangasius-based diet had an intermediate effect compared to the cod- and chicken-based diets. 
When measured in fat gain, feed efficiency of pangasius was significantly elevated compared 
to cod (figure 3.3 D). Furthermore, feed efficiency of the chicken-based diet declined in the 
chicken (restricted)-group (figure 3.3 C).  
 
Differences in weight gain may be caused by variations in digestibility of macronutrients in 
the diet. In order to investigate this, fat and nitrogen content of feces was analyzed and 
apparent fat- and nitrogen-absorption was calculated (figure 3.3 E-F). Mice fed casein had a 
significant lower nitrogen digestibility than mice fed pangasius, but not compared to any other 
group (figure 3.3 E). The group fed cod had lower fat digestibility than mice fed casein and 
chicken, whereas pangasius as protein source had an intermediate effect (figure 3.3 F). 
Comparing the two chicken-fed groups, no significant differences in fat- or nitrogen 





Figure 3.3 Energy intake, feed efficiency and apparent fat and nitrogen digestibility. Energy intake 
from baseline to week nine (A), accumulated energy intake (B), feed efficiency measured in total weight 
gain (C), feed efficiency measured in total fat gain (D), apparent fat digestibility (E) and apparent nitrogen 
digestibility (F). Development in energy intake was analyzed by RM ANOVA. Feed efficiency and nitrogen 
digestibility were analyzed using a one-way ANOVA with multiple comparison (uncorrected Fisher’s LSD) 
of the mean of each experimental group. Fat digestibility was analyzed by Kruskal-Wallis test. Results are 
presented as mean ± SEM. Statistical differences (p ≤ 0.05) are marked by different letters. 
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3.3 Insulin sensitivity and glucose tolerance 
3.3.1 Insulin tolerance test 
After ten weeks, an ITT was performed in order to assess the impact of different protein 
sources on insulin sensitivity. Results are presented in figure 3.4.  Analysis by RM ANOVA 
demonstrates that mice fed chicken and pangasius had impaired insulin sensitivity compered 
to all other groups (figure 3.4 A). Although no significant differences, calculated area over the 
curve (AOC) seems to substantiate this (figure 3.4 C). AOC appeared to decline when body 
weight inclined. Fifteen minutes post insulin injection, blood glucose levels had declined 
significantly more in mice fed casein compared to those fed chicken and pangasius, 
suggesting higher insulin sensitivity in this group (figure 3.4 D). Insulin response after fifteen 
minutes mirrored body weight. After thirty minutes, change in blood glucose was only 
significantly different between the group fed casein and the one fed pangasius (figure 3.4 E). 
Few significant differences were observed in fasting blood glucose, but the mice fed chicken 
(restricted) had lower blood glucose levels than mice fed cod, pangasius and chicken (figure 
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Figure 3.4 Insulin tolerance test. Blood glucose measured during ITT (A), fed blood glucose (B), area 
over the curve (AOC) (C), delta blood glucose 15-0 minutes (D) and delta blood glucose 30-0 minutes 
(E). Blood glucose levels during ITT were analyzed by RM ANOVA. Data B-E were analyzed by one-way 
ANOVA with multiple comparison (uncorrected Fisher’s LSD) of the mean of each experimental group. 





3.3.2 Oral glucose tolerance test 
To evaluate the impact of the different diets on glucose tolerance, an OGTT was performed 
after eleven weeks. The results are presented in figure 3.5. Upon glucose administration, mice 
fed chicken (restricted) had significantly lower blood glucose levels compared to those fed ad 
libitum (figure 3.5 B). RM ANOVA analysis of blood glucose data during the test shows that 
mice fed chicken had reduced glucose tolerance compared to mice fed cod (figure 3.5 A). 
Pangasius-fed mice was neither different from those fed chicken, nor those fed cod. Mice fed 
chicken (restricted) had better glucose tolerance than those fed ad libitum, suggesting that 
reduced glucose tolerance was associated with high body weight. However, calculated 
incremental area under the curve (AUC) (figure 3.5 C), which calculates response to glucose 
administration independent of blood glucose levels at baseline, reveals that the two chicken-
fed groups had a similar response, together with the groups fed casein and cod.  
 
Ultra Sensitive Mouse Insulin ELISA kit was used to measure insulin concentrations in 
plasma collected upon testing and 15 minutes post glucose administration (figure 3.5 D-E). 
Figure 3.5 D demonstrates elevated fasting plasma insulin levels in mice fed pangasius and 
chicken compared to mice fed casein or chicken (restricted). Moreover, fasting plasma insulin 
levels in the group fed pangasius was significantly higher compared to the group fed cod. 
Plasma insulin levels measured after 15 minutes indicates that mice fed chicken had reduced 
insulin sensitivity compared to mice fed casein, cod and pangasius (figure 3.5 E). However, 
this only seemed to be the case when the mice were fed chicken ad libitum and consequently 
was obese. High levels of fasting plasma insulin in mice fed pangasius indicates impaired 
insulin sensitivity. Moreover, compared to the chicken-fed mice, this group did not 
compensate by secreting higher amounts of insulin post glucose administration (figure 3.5 E), 








Figure 3.5 Oral glucose tolerance test. Blood glucose measured during OGTT (A), fasting blood 
glucose (B), incremental area under the curve (AUC) (C), fasting plasma insulin (D) and plasma insulin 
levels after 15 minutes (E). Blood glucose levels during OGTT were analyzed by RM ANOVA. Data B-E 
were analyzed by one-way ANOVA with multiple comparison (uncorrected Fisher’s LSD) of the mean of 
each experimental group. Results are presented as mean ± SEM. Statistical differences (p ≤ 0.05) are 
marked by different letters. 
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3.4 White adipose tissue 
3.4.1 Weight of WAT 
At termination, selected adipose tissues and organs were harvested to investigate the impact 
of different diets on organ weight and adipocyte size. Weight of white adipose tissues are 
presented in figure 3.6. Liver weight, as well as weight of kidneys and m. Tibialis anterior are 
displayed in figure A.1 in appendix VI.  
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W e ig h t  o f  iW A T ,  e W A T  a n d  r W A T
Figure 3.6 Weight of iWAT, eWAT and rWAT. Weigt of iWAT(A), eWAT(B) and rWAT(C) at termination. 
All data were analyzed by one-way ANOVA with multiple comparison (uncorrected Fisher’s LSD) of the 
mean of each experimental group. Results are presented as mean ± SEM. Statistical differences (p ≤ 




Naturally, weight of different adipose tissues appears to be associated with body weight. Mice 
fed casein had a significantly lower fat accumulation than all other groups in both eWAT and 
rWAT (figure 3.6 B-C). Further, pangasius and cod as protein sources promoted lower fat 
accumulation compared to chicken in all three WAT depots (figure 3.6 A-C). There was a 
trend towards an intermediate effect of pangasius, but no significant differences between this 
group and the one fed cod (p = 0.08 in all three depots). 
 
3.4.2 Adipocyte size in iWAT 
The adipocyte size in iWAT was examined by H&E staining of tissue sections, which was 
further studied by microscope and photographed. Mean adipocyte size was calculated by 
using Adiposoft. Results are shown in figure 3.7. The micrographs indicates that body weight 
development determines adipocyte size of iWAT. Differences in mean cell size between the 
two chicken-fed groups supports this. Large hypertrophic adipocytes can be observed in mice 
fed chicken, and mean adipocyte size in this group was similar to the HF/HS-fed reference 
group. Adipocyte size in mice fed pangasius was smaller and casein-fed mice had the smallest 
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Figure 3.7 Adipocyte size in iWAT. Adipocyte micrographs of epididymal WAT (magnified x200) and 
mean adipocyte size. Mean adipocyte size was analyzed by one-way ANOVA with multiple comparison 
(uncorrected Fisher’s LSD) of the mean. Results are presented as mean ± SEM. Statistical differences (p 






3.5 Brown adipose tissue 
Previous studies have observed a whitening of iBAT in mice fed chicken. To further 
investigate the whitening effect of different protein sources, H&E-staining and microscopy 
was carried out on sections of iBAT. BAT possess the ability to burn energy through 
thermogenesis and are consequently an important metabolic organ in mice. Hence, changes in 
BAT activity could affect energy expenditure and body weight gain. In order to investigate if 
such changes could be partially responsible for differences observed in feed efficiency, RT-
qPCR and immunohistochemical staining of UCP1 was conducted.  
 
3.5.1 Adipocyte size and weight of iBAT 
Adipocyte size in iBAT were studied by staining and microscopy. Representative sections 
were photographed and are displayed in figure 3.8 along with weight of iBAT dissected at 
termination.  
 
The micrographs illustrates a change in iBAT morphology, particularly in mice fed chicken 
and cod. In these groups, most brown adipocytes had changed from classical multilocular 
cells to unilocular ones (figure 3.8). The whitening effect of chicken appears to be attributable 
to greater iBAT- and body weight given that the mice fed chicken (restricted) had a more 
classic iBAT morphology. However, iBAT in the group fed pangasius had a more typical 
morphology compared to the one fed cod, despite higher body- and iBAT-weight (figure 3.8). 






































































Adipocyte size and weight of iBAT 
Figure 3.8 Adipocyte size and weight of iBAT. Adipocyte micrographs of interscapular BAT (magnified 
x200) and weight of iBAT at termination. iBAT weight was analyzed by one-way ANOVA with multiple 
comparison (uncorrected Fisher’s LSD) of the mean. Results are presented as mean ± SEM. Statistical 


































Figure 3.9 Gene expression in iBAT. Relative expression of genes associated with brown fat (A) and 
genes involved in triaglycerol synthesis and breakdown. Differences in gene expression were analyzed 
by one-way ANOVA with multiple comparison (uncorrected Fisher’s LSD) of the mean. Results are 
presented as mean ± SEM. Statistical differences (p ≤ 0.05) are marked by different letters. 
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RT-qPCR was used to study gene expression in iBAT (figure 3.9). Genes encoding the brown 
markers UCP1 (Ucp1), iodothyorine deiodinase II (Dio2) and peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (Ppargc1α) was measured (figure 3.9 A). 
Expression levels of genes encoding diacylglycerol acyltransferase (Dgat1), glycerol kinase 
(Gyk) and glycerol-3-phosphate dehydrogenase (Gpd1) was also determined (figure 3.9 B), 
the first protein is involved in TG synthesis whereas the two latter are active in TG 
breakdown.  
 
Few significant differences were observed in gene expression. Expression of markers Ucp1, 
Dio2 and Ppargc1α did not differ between the groups (figure 3.9 A), suggesting similar levels 
of metabolic activity in BAT. Elevated expression of genes involved in TG synthesis and 
breakdown could cause loss of energy through a futile cycling of FAs. Despite elevated 
expression of Gpd1 in the pangasius-fed group compared to the one fed casein, no similar 
trends could be observed in expression of the other genes measured (figure 3.9 B). 
 
3.5.3 Immunohistochemistry 
mRNAs are a highly unstable components with a short half-life. Hence, differences in 
expression rate may not be detected by RT-qPCR due to rapid changes and degradation. In 
order to investigate expression of UCP1 on protein level, immunohistochemical staining of 
UCP1 in iBAT was performed, followed by microscopy. UCP1 expression was quantified by 
ImageJ, and results of microscopy and quantification are displayed in figure 3.10.  
 
Higher expression of UCP1 was detected in the pangasius-fed group compared to the groups 
fed cod and chicken. Calorie restriction led to elevated expression of UCP1 in iBAT. 
Additionally, higher expression of the protein was detected in iBAT from mice fed casein 






































Expression of UCP1 in iBAT 
 
Figure 3.10 Expression of UCP1 in iBAT. Micrographs of immunohistochemically stained iBAT 
(magnified x200) and quantified UCP1 expression. Variations in UCP1 expression were analyzed by one-
way ANOVA with multiple comparison (uncorrected Fisher’s LSD) of the mean. Results are presented as 
mean ± SEM. Statistical differences (p ≤ 0.05) are marked by different letters. 
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4.0 Discussion  
In this study, we demonstrate that a HF/HP diet with pangasius as protein source has an 
intermediate effect on weight gain and fat accumulation compared to similar diets containing 
cod or chicken. This suggests that both amino acid composition and endogenous fat 
composition of the protein source affects the obesogenic potential of the diet. Further, we 
show that calorie restriction attenuates whitening of iBAT. Therefore, the whitening effect of 
chicken as a protein source seen in previous studies (Tastesen, Ronnevik, et al. 2014), seems 
to be a consequence of obesity rather than a cause. However, mice fed pangasius maintained a 
more classical iBAT morphology than those fed cod, despite higher body weight. iBAT 
morphology in mice fed pangasius were similar to casein-fed mice, suggesting that these 
protein sources might share an unknown factor which attenuates whitening of iBAT.    
 
4.1 A HF/HP diet based on chicken is obesogenic relative to one based on 
cod, whereas a pangasius-based diet has an intermediate effect 
4.1.1 Differences in body weight is partially caused by variations in energy intake 
When given similar HP/HF diets containing either cod, pangasius or chicken, mice fed 
chicken had a significantly higher body weight gain compared to those fed cod. Mice fed 
pangasius gained more weight than the cod-fed mice, but less than those fed chicken. 
Moreover, calculated cumulative energy intake in the three different groups revealed a similar 
trend. Intake is highest in the chicken-fed group and lowest in the one fed cod, with the group 
fed pangasius in between, suggesting that differences in body weight may partly be due to 
differences in energy intake. 
 
One possible explanation to the increased feed intake in the chicken-, and partially the 
pangasius-fed group, is elevated levels of endocannabinoids due to higher amounts of 
endogenous n-6 in the diet (table A.5, appendix I). Kirkham et al. (Kirkham et al. 2002) found 
that injections of 2-AG stimulated feeding in rats, supporting the theory that increased 
endocannabinoid signaling alters appetite regulation. Another study found that injection of 
AEA in satiated rats caused increased appetite (Jamshidi and Taylor 2001). Gomes et al. 




Moreover, when ECS was blocked using the CB1 antagonist rimonabant, feed intake 
decreased in fasted and partially satiated rats.  
 
Increased appetite caused by elevated endocannabinoid signaling could explain why mice eat 
more of the n-6 rich chicken diet compared to the cod-based feed, which is lower in n-6 FAs. 
Further, the latter is also high in n-3 FAs, which might contribute to decreased ECS activation 
by lowering the amount of AA available for EC synthesis. When given to rats, a diet enriched 
with krill oil caused decreased concentrations of AEA and 2-AG in visceral adipose tissue and 
lower levels of AA in membrane phospholipids (Batetta et al. 2009). Alvheim et al. (Alvheim 
et al. 2012) also found that the adipogenic effect of a diet rich in LA was inhibited by 
consumption of EPA and DHA.   
 
What the theory of increased EC-signaling does not explain, is the intermediate effect of the 
pangasius based diet on feed intake. This diet is rich in n-6 FAs and low in n-3, similar to the 
diet based on chicken. Still, the pangasius-fed mice had a lower energy intake compared to 
mice fed chicken. One possible explanation to this is the differences in amino acid 
composition between the two diets. A former study found that satiety was greater after 
ingestion of cod compared to chicken, and observed higher plasma levels of taurine after 
consumption of the fish meal (Uhe, Collier, and O'Dea 1992). In our study, the cod- and 
pangasius-based diets had higher levels of taurine relative to the one based on chicken. 
Tastesen et al. (Tastesen, Keenan, et al. 2014) showed that mice fed a HF/HS diet with scallop 
or crab, protein sources high in taurine, had a significantly lower feed intake compared to 
mice fed chicken. They further hypothesize that taurine in the diet might enhance the 
anorexigenic effects of insulin, resulting in lower energy intake. This is supported by another 
study in rats, where taurine supplementation in the drinking water resulted in decreased 
energy intake. Taurine-induced insulin signaling was also observed (Cappelli et al. 2014). It is 
important to notice that other studies have had contradictive results (Tsuboyama-Kasaoka et 
al. 2006). 
 
Differences in palatability, caused by differences in amino acid composition, could also 
contribute to the differences in energy intake between cod-, pangasius- and chicken-fed mice. 
van Aavesaat et al. found that the taste of umami decreased subjective hunger and desire to 




glutamate is known to have an umami taste. Soup enriched with monosodium glutamate have 
been shown to reduce energy intake in women (Miyaki et al. 2016, Imada et al. 2014), 
suggesting that higher levels of glutamate in cod and pangasius could have a satiating effect. 
This is of course only speculation, as the effect of different amino acids on palatability is a 
field that requires more research.  
 
As for the casein-based diet, elevated EC signaling due to high levels of n-6 FAs compared to 
n-3 FAs may partially account for the high energy intake. However, as this diet is high in 
glutamate, the high energy intake in this group is not in agreement with the theory of 
glutamate-induced satiety. It is worth noticing that the casein-diet had a slightly different 
texture, it was a “finer” powder, compared to the ones based on cod, pangasius and chicken. 
Furthermore, mice fed casein had a higher tendency to urinate in their food bowl. These are 
important aspects to consider when evaluating energy intake in the casein-fed group, since 
they made it harder to measure feed intake as accurately as in the other groups.   
 
4.1.2 The protein- and fat source in the diet varied in their effect on feed efficiency 
Interestingly, it seems that variations in energy intake is not the only reason for differences in 
body weight between the groups. The HF/HP diets also differ in their effect on feed 
efficiency. The chicken-based diet generates a higher feed efficiency than the one based on 
cod, whereas pangasius as protein source have an intermediate effect. Furthermore, analysis 
of apparent fat- and nitrogen digestibility makes it clear that the differences in feed efficiency 
is not due to varied absorption of nitrogen. As for apparent fat absorption, the cod-fed mice 
differ significantly from those fed chicken. Elevated fat excretion in this group may partially 
explain the differences in feed efficiency compared to the chicken-based diet. However, since 
the casein-fed mice have the highest apparent fat digestibility, elevated fat absorption does not 
explain the higher obesogenic effect of the chicken-based diet.  
 
It seems that the ECS modulates energy expenditure as well as feed intake. Therefore, 
increased EC signaling may partially explain differences in feed efficiency as well as feed 
intake. An experiment by Cota et al. (Cota et al. 2003) showed that adult CB1 knockout mice 
had increased energy expenditure compared to wild type littermates. Decreased glucose 
uptake by muscle has also been suggested as a mechanism of which an overactive ESC 




could stimulate PPAR-γ in mouse preadipocytes (Matias et al. 2006), an activation which has 
been shown to elevate feed efficiency in rats treated with PPAR-agonists (de Souza et al. 
2001, Larsen et al. 2003). 
   
Like the differences in feed intake, differences in feed efficiency can only partially be 
explained by impaired EC signaling. The intermediate effect of pangasius suggests that amino 
acid composition, as well as FA composition, affects feed efficiency. In mice fed a HF diet, 
taurine supplementation has been shown to elevate resting oxygen consumption, suggesting 
higher resting energy expenditure (Tsuboyama-Kasaoka et al. 2006). Moreover, Lin and 
colleagues observed lower body weight gain in mice fed a HF taurine enriched diet compared 
to a HF control group, despite pair feeding of the groups (Lin et al. 2013). Higher taurine 
content may therefore contribute to lower feed efficiency in the cod-based, and partially the 
pangasius-based diet.  
 
When discussing feed efficiency, activity level is an important factor to consider. We did not 
do any measurements on activity level in this experiment. A previous study by our group 
found that mice fed pork had a tendency towards lower activity level compared to mice fed 
casein, although no significant differences were reported (Liisberg, Myrmel, et al. 2016). 
However, the differences in feed efficiency seen between the two chicken-fed groups suggests 
that higher feed efficiency due to lower activity levels is not caused by the protein source 
itself. Nonetheless, decreased physical activity due to high body weight could be a sort of 
vicious circle, enhancing the obesogenic effect of the diet. 
 
The decreased feed efficiency in mice fed chicken (restricted) was a somewhat surprising 
discovery. Higher activity levels due to lower body weight could be part of the explanation. 
Further, it might be that the mice in this group received enough energy only to cover their 
basal metabolism, leaving no energy available for excess fat mass accumulation. Also, 
intermittent fasting is likely to alter metabolic processes, e.g. increase lipolysis (Tinsley and 
La Bounty 2015). 
 
Increased energy expenditure due to higher thermogenesis in BAT would affect feed 
efficiency; this will be further discussed in section 4.2. Furthermore, differences in body 




4.1.3 Low lean mass in chicken-fed mice may increase feed efficiency 
The MRI scan conducted in week nine revealed higher fat mass gain in the chicken-fed group 
compared to the group fed cod and pangasius. Further, the group fed pangasius had gained 
more fat than the one fed cod. Total fat mass was higher in mice fed chicken than mice fed 
cod, and there was a trend towards higher fat mass compared to pangasius-fed mice (p = 
0.09). Adipose tissue functions as the main energy storage in vertebrates, thus a positive 
correlation between fat mass and body weight is natural. An in vitro study found that CB1 
receptors are present in eWAT of C57BL/6N mice. Further, stimulation with a CB1 agonist 
dose-dependently increased lipoprotein lipase activity in these cells, showing that increased 
EC signaling may directly promote fat accumulation (Cota et al. 2003). However, this does 
not seem to be the case in our study. Micrographs of iWAT indicates that degree of 
hypotrophy in WAT adipocytes is determined by weight gain, not diet, as adipocyte size in 
iWAT of the calorie restricted group were similar to the one fed cod. 
 
The casein- and cod-based diets seems superior to the one based on chicken regarding lean 
mass-gain. Of notice, obesity has been observed to cause increased intramuscular lipid storage 
(Goodpaster et al. 2000, Storlien et al. 1991), possibly resulting in slightly decreased muscle 
mass. Thus, decreased lean mass may be a consequence of weight gain. However, a similar 
trend can be observed in both obese and lean chicken-fed mice, suggesting that lean mass is 
not entirely decided by body weight. One possible explanation to the low lean mass in the 
group fed chicken (restricted) could be an elevated protein metabolism in order to compensate 
for the reduced energy intake. Nonetheless, this seems somewhat unlikely since energy intake 
in this group is similar to the one fed cod. Fasting may increase proteolysis, but short-term 
fasting periods (20-28 hours) does not appear to alter body protein metabolism (Tinsley and 
La Bounty 2015).   
 
Lean mass, consisting mainly of muscle mass, is known to have higher metabolic activity 
compared with fat mass, and increased lean mass is associated with higher resting metabolic 
rate (Speakman and Selman 2003). It is therefore possible that observed differences in lean 
mass affects energy expenditure and that low lean mass in the chicken-fed group is a 
contributing factor to the high feed efficiency. The trend towards an intermediate effect of 
pangasius suggest that both amino acid composition and FA-composition of the diet affects 




4.2 Body mass determines glucose tolerance and insulin sensitivity 
Development of insulin resistance and diabetes type 2 are strongly related to overweight and 
obesity (WHO 2003). In concurrence with this, we observed impaired glucose tolerance and 
insulin sensitivity when body weight increased. RM ANOVA, revealing poor insulin response 
in the chicken- and pangasius-fed groups compared to the groups fed casein and chicken 
(restricted), supports this. High plasma insulin levels measured during OGTT show that 
despite little differences in AUC, the obese chicken fed mice have reduced inulin sensitivity 
compared with the other groups. Interestingly, while having the highest levels of fasting 
plasma insulin, the pangasius-fed group have similar plasma insulin levels as the cod- and 
casein-fed group fifteen minutes after glucose administration. Although explaining the high 
AUC of this group, it raises the question of why this group seems to have impaired glucose-
stimulated insulin secretion.  
 
Previous studies have suggested that taurine supplementation in obese mice improves glucose 
tolerance and insulin sensitivity (Batista et al. 2013, El Mesallamy et al. 2010). Notably, 
supplementation also attenuated body weight gain, underlining the close relationship between 
body weight gain and reduced insulin sensitivity. In concurrence with this, mice fed cod, the 
diet with the highest levels of taurine, have higher insulin sensitivity than mice fed chicken or 
pangasius. However, higher taurine content in the pangasius based diet compared with the one 
based on chicken did not seem to improve insulin sensitivity. Instead, in accordance with 
previous studies (Liisberg, Myrmel, et al. 2016), development of insulin resistance and 
glucose intolerance are consistent with increased body weight.  
 
4.3 Calorie restriction attenuates whitening of iBAT, but changes are not 
solemnly decided by body weight 
4.3.1 The whitening effect of chicken on iBAT morphology is weight related 
One reason for including the calorie restricted chicken-fed group was to investigate whether 
the BAT-whitening effect of a chicken-based diet observed in previous studies is caused by 
the protein source, or rather a consequence of obesity. Micrographs reveals a classic 
morphology in iBAT of mice fed chicken (restricted) relative to those fed ad libitum, 




by Cinti et al. (Cinti et al. 1997), who further proposes low sympathetic stimulation as a 
possible cause. Sympathetic activation of BAT increases thermogenesis, and thus lipid 
consumption. Lowered sympathetic activity associated with obesity could therefore increase 
lipid accumulation in BAT (Cannon and Nedergaard 2004). Moreover, as discussed in section 
4.1.2, obesity may cause decreased levels of physical activity. Higher activity levels in the 
mice fed chicken (restricted) could cause enhanced sympathetic stimulated thermogenesis in 
BAT, which may attenuate whitening.  
 
Results from the two chicken-fed groups indicates that whitening of BAT is a consequence of 
obesity. However, lipid accumulation in iBAT was higher in cod-fed mice compared with 
those fed pangasius, despite lower body weight. This reveals the possible existence of other 
unknown factors, apart from obesity, that could either induce or attenuate BAT-whitening.   
 
4.3.2 Pangasius attenuates obesity-induced whitening of iBAT 
Micrographs of iBAT from mice fed casein, the group with the lowest body weight, shows a 
relatively classic BAT morphology. Ergo, casein as protein source either directly or through 
weight-regulating mechanisms, attenuates whitening of BAT. As stated in the previous 
section, micrographs of iBAT from mice fed pangasius implies that body weight alone does 
not determine the degree of whitening in BAT. Activation of PPAR-γ has been found to 
increase adipocyte size in BAT (Okamoto et al. 2007), offering one possible mechanism of 
BAT whitening. As previously discussed, increased EC activity has been observed to 
stimulate PPAR-γ in mice, meaning higher amounts of n-6 FAs in the diet could induce 
whitening of BAT. Furthermore, administration of the CB1 antagonist rimonabant resulted in 
decreased lipid droplet size in BAT from mice (Boon et al. 2014). Of notice, treatment with 
rimonabant also caused weight loss. The results from our study are clearly contradicting, 
given that the pangasius based diet contains high amounts of n-6 FAs. Another possible 
explanation for the differences observed in our experimental groups could be that whitening 
of iBAT in mice fed chicken, and to a lesser extent cod, are obesity related. Further, the 
pangasius- and casein-based diet share a similar unknown factor, possibly within their amino 
acid profile, that attenuates obesity-induced BAT whitening. One suggestion could be higher 
levels of BCAA. Nonetheless, the impact of different diets and amino acids on whitening of 




4.3.3 Increased iBAT activation is not the main cause of differences in feed efficiency   
Few variations were observed in gene expression in iBAT. Elevated expression of Gpd1 in 
mice fed pangasius relative to mice fed casein may suggest higher levels of TG breakdown. 
This is not reflected in body weight gain, as the pangasius-fed group had higher fat 
accumulation and body weight gain compared to the group fed cod. Given the short half-life 
of mRNA, the ability to detect differences in gene expression may get lost due to rapid 
degradation. In concurrence with this, immunohistochemical staining of UCP1 revealed 
significant differences in UCP1 expression on protein level. Amount of UCP1 in BAT 
appears to decrease with increased whitening of the tissue. Whether lower UCP1 levels and 
lower thermogenesis causes whitening or whitening causes lower amounts of UCP1 is 
unknown.  
 
Since BAT is an important metabolic organ in mice, we hypothesized that variations observed 
in feed efficiency may be caused by changes in BAT activity. Further, we also speculated that 
such differences, if present, are attributable to differences in FA composition of the diets. The 
endocannabinoid system is believed to influence BAT activity, and administration of 
rimonabant to rats has been observed to increase expression of Ucp1 in BAT (Verty, Allen, 
and Oldfield 2009). An increase in BAT temperature, indicating higher thermogenesis, was 
also observed. Boon and colleagues showed similar results in mice, where administration of 
rimonabant resulted in elevated Ucp1 expression accompanied with more intense 
immunohistochemical staining of UCP1 (Boon et al. 2014).  Surprisingly, in our study highest 
amounts of UCP1 was found not only in the lean casein- and chicken (restricted)-fed mice, 
but also in mice fed pangasius. This does not reject the theory that elevated EC signaling, due 
to increased intake of n-6 FA, decreases thermogenesis in BAT. However, it highlights the 









4.4 The animal model and relevance to humans  
This is an animal study, and it is important to state that the results of this study cannot be 
directly applied to humans. However, human studies are far more expensive and time 
consuming to conduct. Additionally, such studies offer many ethical limitations and a human 
environment is far less controllable compared to that of animals. Hence, animal studies are an 
important part of basic nutritional research and results from such studies may give valuable 
information on biological mechanisms. 
 
Mice are one of the most commonly used animal models in nutritional research since they are 
similar to humans both genetically and physiologically. Of notice, mice used for animal 
research are usually from inbred strains, which have less genetic variations than humans do. 
As previously stated, the C57BL/6J mouse model used in this experiment is characterized by 
its ability to develop obesity, hyperglycemia and hyperinsulinemia when fed a HF diet. It is 
therefore a suitable model for studying the pathophysiology of obesity, undergoing similar 
changes as the ones observed in humans. The monotonous mouse diets in this experiment are 
very different from a varied human food intake. However, in concordance with an increased 
focus on food and dietary patterns rather than single isolated nutrients (Mozaffarian 2016, 
Helsedirektoratet 2014), the main focus in our experiment was natural protein sources rather 














4.5 Future perspectives 
We observed an elevated feed intake in mice fed the chicken-based diet compared to those fed 
cod, with an intermediate effect when pangasius was used as protein source. Altered EC 
signaling could cause such variations. In order to draw any conclusions on whether this may 
be the case in our study, analysis of endocannabinoid levels in tissues and/or plasma are 
essential. Analysis of amino acids in plasma could also be of use, as this may reveal 
similarities/differences in the cod- and pangasius-based diet compared to the one based on 
chicken and help elaborate the importance and effect of the different amino acids.   
 
In this study, we focused on changes in BAT. We cannot exclude the possibility that different 
diets induced formation of brown or beige adipocytes in WAT. Such changes could affect 
energy expenditure and contribute to the variations observed in feed efficiency. A RT-qPCR 
analysis of Ucp1 expression and other brown markers in WAT could therefore be of 
relevance. Further, histology and analysis of gene expression in liver may be of interest, as 
liver steatosis, obesity and insulin resistance are closely related. Investigations on gut 
microbiota could also be conducted since duodenum, jejunum, ileum and colon were 
harvested at termination. 
 
Diet-induced obesity was observed in mice fed a HF/HP diet based on chicken, and to some 
degree pangasius, relative to similar diets based on casein and cod. Carbohydrate content was 
similar in all three diets. It would be interesting to see if mice still develops obesity when fed 
a HF/HP diet if the carbohydrates are changed from sugar and starch to carbohydrates with 
lower glycemic index. To study the obesogenic effect of different protein sources in other 
diets, such as a LF diet or a HF/HS diet may also be of use.  
 
Last but not least, it would be of great importance to investigate if similar results can be 










5.0 Conclusion  
The obesogenic effect of a HF/HP diet in C57BL/6J mice is contingent upon the protein 
source used. Chicken as protein source are obesogenic relative to cod, whereas pangasius has 
an intermediate effect. Thus, it appears both FA- and amino acid composition determines the 
obesogenic effect of HF/HP diets. Further, various HF/HP diets differ in impact on iBAT 
morphology and levels of UCP1. Calorie restriction attenuates this, but type of protein source 
used is also a determining factor. Protein from pangasius and casein appears expedient in this 
context, and so diversities in body weight gain are not solemnly attributable to altered 
appearance and activity in BAT. Body weight appears to be the main determining factor in 
development of insulin resistance.  
 
To understand the underlying mechanisms responsible for the unequal obesogenic potential of 
different proteins, further research is required. Since high protein diets are popular methods of 
weight management and weight loss in humans, results from this study also highlight the 




















Alvheim, A. R., M. K. Malde, D. Osei-Hyiaman, Y. H. Lin, R. J. Pawlosky, L. Madsen, K. 
Kristiansen, L. Froyland, and J. R. Hibbeln. 2012. "Dietary linoleic acid elevates endogenous 
2-AG and anandamide and induces obesity."  Obesity (Silver Spring) 20 (10):1984-94. doi: 
10.1038/oby.2012.38. 
Batetta, B., M. Griinari, G. Carta, E. Murru, A. Ligresti, L. Cordeddu, E. Giordano, F. Sanna, T. 
Bisogno, S. Uda, M. Collu, I. Bruheim, V. Di Marzo, and S. Banni. 2009. "Endocannabinoids 
may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators 
in obese Zucker rats."  J Nutr 139 (8):1495-501. doi: 10.3945/jn.109.104844. 
Batista, T. M., R. A. Ribeiro, P. M. da Silva, R. L. Camargo, P. C. Lollo, A. C. Boschero, and E. M. 
Carneiro. 2013. "Taurine supplementation improves liver glucose control in normal protein 
and malnourished mice fed a high-fat diet."  Mol Nutr Food Res 57 (3):423-34. doi: 
10.1002/mnfr.201200345. 
Bere, E.; Øverby, N.C. 2011. "Energi." In Om mat og ernæring, page 34. Kristiansand: 
Høyskoleforlaget AS. 
Black, B. L., J. Croom, E. J. Eisen, A. E. Petro, C. L. Edwards, and R. S. Surwit. 1998. "Differential 
effects of fat and sucrose on body composition in A/J and C57BL/6 mice."  Metabolism 47 
(11):1354-9. 
Blasbalg, T. L., J. R. Hibbeln, C. E. Ramsden, S. F. Majchrzak, and R. R. Rawlings. 2011. "Changes 
in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th 
century."  Am J Clin Nutr 93 (5):950-62. doi: 10.3945/ajcn.110.006643. 
Boon, M. R., S. Kooijman, A. D. van Dam, L. R. Pelgrom, J. F. Berbee, C. A. Visseren, R. C. van 
Aggele, A. M. van den Hoek, H. C. Sips, M. Lombes, L. M. Havekes, J. T. Tamsma, B. 
Guigas, O. C. Meijer, J. W. Jukema, and P. C. Rensen. 2014. "Peripheral cannabinoid 1 
receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity."  
Faseb j 28 (12):5361-75. doi: 10.1096/fj.13-247643. 
Cannon, B., and J. Nedergaard. 2004. "Brown adipose tissue: function and physiological significance."  
Physiol Rev 84 (1):277-359. doi: 10.1152/physrev.00015.2003. 
Cappelli, A. P., C. C. Zoppi, H. C. Barbosa-Sampaio, J. M. Costa, Jr., A. O. Protzek, P. N. Morato, A. 
C. Boschero, and E. M. Carneiro. 2014. "Taurine-induced insulin signalling improvement of 
obese malnourished mice is associated with redox balance and protein phosphatases activity 
modulation."  Liver Int 34 (5):771-83. doi: 10.1111/liv.12291. 
Cinti, S. 2009. "Transdifferentiation properties of adipocytes in the adipose organ."  Am J Physiol 
Endocrinol Metab 297 (5):E977-86. doi: 10.1152/ajpendo.00183.2009. 
Cinti, S., R. C. Frederich, M. C. Zingaretti, R. De Matteis, J. S. Flier, and B. B. Lowell. 1997. 
"Immunohistochemical localization of leptin and uncoupling protein in white and brown 
adipose tissue."  Endocrinology 138 (2):797-804. doi: 10.1210/endo.138.2.4908. 
Cota, D., G. Marsicano, M. Tschop, Y. Grubler, C. Flachskamm, M. Schubert, D. Auer, A. 
Yassouridis, C. Thone-Reineke, S. Ortmann, F. Tomassoni, C. Cervino, E. Nisoli, A. C. 
Linthorst, R. Pasquali, B. Lutz, G. K. Stalla, and U. Pagotto. 2003. "The endogenous 
cannabinoid system affects energy balance via central orexigenic drive and peripheral 
lipogenesis."  J Clin Invest 112 (3):423-31. doi: 10.1172/jci17725. 
Cypess, A. M., S. Lehman, G. Williams, I. Tal, D. Rodman, A. B. Goldfine, F. C. Kuo, E. L. Palmer, 
Y. H. Tseng, A. Doria, G. M. Kolodny, and C. R. Kahn. 2009. "Identification and importance 
of brown adipose tissue in adult humans."  N Engl J Med 360 (15):1509-17. doi: 
10.1056/NEJMoa0810780. 
de Lorgeril, M., and P. Salen. 2012. "New insights into the health effects of dietary saturated and 
omega-6 and omega-3 polyunsaturated fatty acids."  BMC Med 10:50. doi: 10.1186/1741-
7015-10-50. 
de Souza, C. J., M. Eckhardt, K. Gagen, M. Dong, W. Chen, D. Laurent, and B. F. Burkey. 2001. 
"Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin 




El Mesallamy, H. O., E. El-Demerdash, L. N. Hammad, and H. M. El Magdoub. 2010. "Effect of 
taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high 
fructose diet induced insulin resistance."  Diabetol Metab Syndr 2:46. doi: 10.1186/1758-
5996-2-46. 
FAO. 2010. "Fats and fatty acids in human nutrition." Food and Agriculture Organization of the 
United Nations, Accessed 03.16.16. 
http://www.who.int/nutrition/publications/nutrientrequirements/fatsandfattyacids_humannutrit
ion/en/. 
FAO. 2013. "The State of Food and Agriculture." Food and Agriculture Organization of the United 
Nations Accessed 01.13.16. http://www.fao.org/docrep/018/i3300e/i3300e.pdf. 
Fruhbeck, G., J. Gomez-Ambrosi, F. J. Muruzabal, and M. A. Burrell. 2001. "The adipocyte: a model 
for integration of endocrine and metabolic signaling in energy metabolism regulation."  Am J 
Physiol Endocrinol Metab 280 (6):E827-47. 
Galarraga, M., J. Campion, A. Munoz-Barrutia, N. Boque, H. Moreno, J. A. Martinez, F. Milagro, and 
C. Ortiz-de-Solorzano. 2012. "Adiposoft: automated software for the analysis of white adipose 
tissue cellularity in histological sections."  J Lipid Res 53 (12):2791-6. doi: 
10.1194/jlr.D023788. 
Gerrior, S., Bente, L. & Hiza, H. 2004. Nutrient Content of the U.S. Food Supply, 1909-2000. (Home 
Economics Research Report No. 56). U.S. Department of Agriculture, Center for Nutrition 
Policy and Promotion. 
Gilbert, J. A., N. T. Bendsen, A. Tremblay, and A. Astrup. 2011. "Effect of proteins from different 
sources on body composition."  Nutr Metab Cardiovasc Dis 21 Suppl 2:B16-31. doi: 
10.1016/j.numecd.2010.12.008. 
Gomez, R., M. Navarro, B. Ferrer, J. M. Trigo, A. Bilbao, I. Del Arco, A. Cippitelli, F. Nava, D. 
Piomelli, and F. Rodriguez de Fonseca. 2002. "A peripheral mechanism for CB1 cannabinoid 
receptor-dependent modulation of feeding."  J Neurosci 22 (21):9612-7. 
Goodpaster, B. H., R. Theriault, S. C. Watkins, and D. E. Kelley. 2000. "Intramuscular lipid content is 
increased in obesity and decreased by weight loss."  Metabolism 49 (4):467-72. 
Goyens, P. L., M. E. Spilker, P. L. Zock, M. B. Katan, and R. P. Mensink. 2006. "Conversion of 
alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid 
and linoleic acid in the diet and not by their ratio."  Am J Clin Nutr 84 (1):44-53. 
Halton, T. L., and F. B. Hu. 2004. "The effects of high protein diets on thermogenesis, satiety and 
weight loss: a critical review."  J Am Coll Nutr 23 (5):373-85. 
Harris, W. S. 2006. "The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses."  
Curr Atheroscler Rep 8 (6):453-9. 
Harris, W. S., B. Assaad, and W. C. Poston. 2006. "Tissue omega-6/omega-3 fatty acid ratio and risk 
for coronary artery disease."  Am J Cardiol 98 (4a):19i-26i. doi: 
10.1016/j.amjcard.2005.12.023. 
Helsedirektoratet. 2014. Anbefalinger om kosthold, ernæring og fysisk aktivitet. 
Himms-Hagen, J., A. Melnyk, M. C. Zingaretti, E. Ceresi, G. Barbatelli, and S. Cinti. 2000. 
"Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white 
adipocytes."  Am J Physiol Cell Physiol 279 (3):C670-81. 
Imada, T., S. S. Hao, K. Torii, and E. Kimura. 2014. "Supplementing chicken broth with monosodium 
glutamate reduces energy intake from high fat and sweet snacks in middle-aged healthy 
women."  Appetite 79:158-65. doi: 10.1016/j.appet.2014.04.011. 
Jamshidi, N., and D. A. Taylor. 2001. "Anandamide administration into the ventromedial 
hypothalamus stimulates appetite in rats."  Br J Pharmacol 134 (6):1151-4. doi: 
10.1038/sj.bjp.0704379. 
Johnson, G. H., and K. Fritsche. 2012. "Effect of dietary linoleic acid on markers of inflammation in 
healthy persons: a systematic review of randomized controlled trials."  J Acad Nutr Diet 112 
(7):1029-41, 1041.e1-15. doi: 10.1016/j.jand.2012.03.029. 
Kim, J., Y. Li, and B. A. Watkins. 2011. "Endocannabinoid signaling and energy metabolism: a target 





Kirkham, T. C., C. M. Williams, F. Fezza, and V. Di Marzo. 2002. "Endocannabinoid levels in rat 
limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of 
eating by 2-arachidonoyl glycerol."  Br J Pharmacol 136 (4):550-7. doi: 
10.1038/sj.bjp.0704767. 
Kyrou, I., H. S. Randeva, and M. O. Weickert. 2000. "Clinical Problems Caused by Obesity." In 
Endotext, edited by L. J. De Groot, P. Beck-Peccoz, G. Chrousos, K. Dungan, A. Grossman, J. 
M. Hershman, C. Koch, R. McLachlan, M. New, R. Rebar, F. Singer, A. Vinik and M. O. 
Weickert. South Dartmouth (MA): MDText.com, Inc. 
Larsen, P. J., P. B. Jensen, R. V. Sorensen, L. K. Larsen, N. Vrang, E. M. Wulff, and K. Wassermann. 
2003. "Differential influences of peroxisome proliferator-activated receptors gamma and -
alpha on food intake and energy homeostasis."  Diabetes 52 (9):2249-59. 
Leidy, H. J., N. S. Carnell, R. D. Mattes, and W. W. Campbell. 2007. "Higher protein intake preserves 
lean mass and satiety with weight loss in pre-obese and obese women."  Obesity (Silver 
Spring) 15 (2):421-9. doi: 10.1038/oby.2007.531. 
Ley, R. E., P. J. Turnbaugh, S. Klein, and J. I. Gordon. 2006. "Microbial ecology: human gut microbes 
associated with obesity."  Nature 444 (7122):1022-3. doi: 10.1038/4441022a. 
Liisberg, U., K. R. Fauske, O. Kuda, E. Fjaere, L. S. Myrmel, N. Norberg, L. Froyland, I. E. Graff, B. 
Liaset, K. Kristiansen, J. Kopecky, and L. Madsen. 2016. "Intake of a Western diet containing 
cod instead of pork alters fatty acid composition in tissue phospholipids and attenuates obesity 
and hepatic lipid accumulation in mice."  J Nutr Biochem 33:119-127. doi: 
10.1016/j.jnutbio.2016.03.014. 
Liisberg, Ulrike, Lene Secher Myrmel, Even Fjære, Alexander K. Rønnevik, Susanne Bjelland, Kristin 
Røen Fauske, Jacob Bak Holm, Astrid Linde Basse, Jacob B. Hansen, Bjørn Liaset, Karsten 
Kristiansen, and Lise Madsen. 2016. "The protein source determines the potential of high 
protein diets to attenuate obesity development in C57BL/6J mice."  Adipocyte:1-16. doi: 
10.1080/21623945.2015.1122855. 
Lin, S., S. Hirai, Y. Yamaguchi, T. Goto, N. Takahashi, F. Tani, C. Mutoh, T. Sakurai, S. Murakami, 
R. Yu, and T. Kawada. 2013. "Taurine improves obesity-induced inflammatory responses and 
modulates the unbalanced phenotype of adipose tissue macrophages."  Mol Nutr Food Res 57 
(12):2155-65. doi: 10.1002/mnfr.201300150. 
Liu, Y. L., I. P. Connoley, C. A. Wilson, and M. J. Stock. 2005. "Effects of the cannabinoid CB1 
receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in 
Lep(ob)/Lep(ob) mice."  Int J Obes (Lond) 29 (2):183-7. doi: 10.1038/sj.ijo.0802847. 
Loncar, D., B. A. Afzelius, and B. Cannon. 1988. "Epididymal white adipose tissue after cold stress in 
rats. I. Nonmitochondrial changes."  J Ultrastruct Mol Struct Res 101 (2-3):109-22. 
Lucan, S. C., and J. J. DiNicolantonio. 2015. "How calorie-focused thinking about obesity and related 
diseases may mislead and harm public health. An alternative."  Public Health Nutr 18 (4):571-
81. doi: 10.1017/s1368980014002559. 
Matias, I., and V. Di Marzo. 2007. "Endocannabinoids and the control of energy balance."  Trends 
Endocrinol Metab 18 (1):27-37. doi: 10.1016/j.tem.2006.11.006. 
Matias, I., M. P. Gonthier, P. Orlando, V. Martiadis, L. De Petrocellis, C. Cervino, S. Petrosino, L. 
Hoareau, F. Festy, R. Pasquali, R. Roche, M. Maj, U. Pagotto, P. Monteleone, and V. Di 
Marzo. 2006. "Regulation, function, and dysregulation of endocannabinoids in models of 
adipose and beta-pancreatic cells and in obesity and hyperglycemia."  J Clin Endocrinol 
Metab 91 (8):3171-80. doi: 10.1210/jc.2005-2679. 
Miyaki, T., T. Imada, S. S. Hao, and E. Kimura. 2016. "Monosodium L-glutamate in soup reduces 
subsequent energy intake from high-fat savoury food in overweight and obese women."  Br J 
Nutr 115 (1):176-84. doi: 10.1017/s0007114515004031. 
Mozaffarian, D. 2016. "Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and 
Obesity: A Comprehensive Review."  Circulation 133 (2):187-225. doi: 
10.1161/circulationaha.115.018585. 
O'Rahilly, S., and I. S. Farooqi. 2000. "The Genetics of Obesity in Humans." In Endotext, edited by L. 
J. De Groot, P. Beck-Peccoz, G. Chrousos, K. Dungan, A. Grossman, J. M. Hershman, C. 
Koch, R. McLachlan, M. New, R. Rebar, F. Singer, A. Vinik and M. O. Weickert. South 




Okamoto, Y., H. Higashiyama, H. Inoue, M. Kanematsu, M. Kinoshita, and S. Asano. 2007. 
"Quantitative image analysis in adipose tissue using an automated image analysis system: 
differential effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist on 
white and brown adipose tissue morphology in AKR obese and db/db diabetic mice."  Pathol 
Int 57 (6):369-77. doi: 10.1111/j.1440-1827.2007.02109.x. 
Peirce, V., S. Carobbio, and A. Vidal-Puig. 2014. "The different shades of fat."  Nature 510 (7503):76-
83. doi: 10.1038/nature13477. 
Poekes, L., N. Lanthier, and I. A. Leclercq. 2015. "Brown adipose tissue: a potential target in the fight 
against obesity and the metabolic syndrome."  Clin Sci (Lond) 129 (11):933-49. doi: 
10.1042/cs20150339. 
Rodriguez, A., S. Ezquerro, L. Mendez-Gimenez, S. Becerril, and G. Fruhbeck. 2015. "Revisiting the 
adipocyte: a model for integration of cytokine signaling in the regulation of energy 
metabolism."  Am J Physiol Endocrinol Metab 309 (8):E691-714. doi: 
10.1152/ajpendo.00297.2015. 
Rosenwald, M., A. Perdikari, T. Rulicke, and C. Wolfrum. 2013. "Bi-directional interconversion of 
brite and white adipocytes."  Nat Cell Biol 15 (6):659-67. doi: 10.1038/ncb2740. 
Rossmeisl, M., Z. M. Jilkova, O. Kuda, T. Jelenik, D. Medrikova, B. Stankova, B. Kristinsson, G. G. 
Haraldsson, H. Svensen, I. Stoknes, P. Sjovall, Y. Magnusson, M. G. Balvers, K. C. 
Verhoeckx, E. Tvrzicka, M. Bryhn, and J. Kopecky. 2012. "Metabolic effects of n-3 PUFA as 
phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of 
endocannabinoids."  PLoS One 7 (6):e38834. doi: 10.1371/journal.pone.0038834. 
Russo, G. L. 2009. "Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical 
implications in cardiovascular prevention."  Biochem Pharmacol 77 (6):937-46. doi: 
10.1016/j.bcp.2008.10.020. 
Sanchez-Gurmaches, J., C. M. Hung, C. A. Sparks, Y. Tang, H. Li, and D. A. Guertin. 2012. "PTEN 
loss in the Myf5 lineage redistributes body fat and reveals subsets of white adipocytes that 
arise from Myf5 precursors."  Cell Metab 16 (3):348-62. doi: 10.1016/j.cmet.2012.08.003. 
Seale, P., B. Bjork, W. Yang, S. Kajimura, S. Chin, S. Kuang, A. Scime, S. Devarakonda, H. M. 
Conroe, H. Erdjument-Bromage, P. Tempst, M. A. Rudnicki, D. R. Beier, and B. M. 
Spiegelman. 2008. "PRDM16 controls a brown fat/skeletal muscle switch."  Nature 454 
(7207):961-7. doi: 10.1038/nature07182. 
Simopoulos, A. P. 1999. "Essential fatty acids in health and chronic disease."  Am J Clin Nutr 70 (3 
Suppl):560s-569s. 
Simopoulos, A. P. 2002. "The importance of the ratio of omega-6/omega-3 essential fatty acids."  
Biomed Pharmacother 56 (8):365-79. 
Simopoulos, A. P. 2016. "An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk 
for Obesity."  Nutrients 8 (3). doi: 10.3390/nu8030128. 
Speakman, J. R., and C. Selman. 2003. "Physical activity and resting metabolic rate."  Proc Nutr Soc 
62 (3):621-34. doi: 10.1079/pns2003282. 
Storlien, L. H., A. B. Jenkins, D. J. Chisholm, W. S. Pascoe, S. Khouri, and E. W. Kraegen. 1991. 
"Influence of dietary fat composition on development of insulin resistance in rats. 
Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid."  
Diabetes 40 (2):280-9. 
Surwit, R. S., C. M. Kuhn, C. Cochrane, J. A. McCubbin, and M. N. Feinglos. 1988. "Diet-induced 
type II diabetes in C57BL/6J mice."  Diabetes 37 (9):1163-7. 
Tappy, L. 1996. "Thermic effect of food and sympathetic nervous system activity in humans."  Reprod 
Nutr Dev 36 (4):391-7. 
Tastesen, H. S., A. H. Keenan, L. Madsen, K. Kristiansen, and B. Liaset. 2014. "Scallop protein with 
endogenous high taurine and glycine content prevents high-fat, high-sucrose-induced obesity 
and improves plasma lipid profile in male C57BL/6J mice."  Amino Acids 46 (7):1659-71. doi: 
10.1007/s00726-014-1715-1. 
Tastesen, H. S., A. K. Ronnevik, K. Borkowski, L. Madsen, K. Kristiansen, and B. Liaset. 2014. "A 
mixture of cod and scallop protein reduces adiposity and improves glucose tolerance in high-
fat fed male C57BL/6J mice."  PLoS One 9 (11):e112859. doi: 10.1371/journal.pone.0112859. 




Te Morenga, L., and J. Mann. 2012. "The role of high-protein diets in body weight management and 
health."  Br J Nutr 108 Suppl 2:S130-8. doi: 10.1017/s0007114512002437. 
Tinsley, G. M., and P. M. La Bounty. 2015. "Effects of intermittent fasting on body composition and 
clinical health markers in humans."  Nutr Rev 73 (10):661-74. doi: 10.1093/nutrit/nuv041. 
Tsuboyama-Kasaoka, N., C. Shozawa, K. Sano, Y. Kamei, S. Kasaoka, Y. Hosokawa, and O. Ezaki. 
2006. "Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting 
obesity."  Endocrinology 147 (7):3276-84. doi: 10.1210/en.2005-1007. 
Uhe, A. M., G. R. Collier, and K. O'Dea. 1992. "A comparison of the effects of beef, chicken and fish 
protein on satiety and amino acid profiles in lean male subjects."  J Nutr 122 (3):467-72. 
van Avesaat, M., F. J. Troost, D. Ripken, J. Peters, H. F. Hendriks, and A. A. Masclee. 2015. 
"Intraduodenal infusion of a combination of tastants decreases food intake in humans."  Am J 
Clin Nutr 102 (4):729-35. doi: 10.3945/ajcn.115.113266. 
van Dam, R. M., and J. C. Seidell. 2007. "Carbohydrate intake and obesity."  Eur J Clin Nutr 61 Suppl 
1:S75-99. doi: 10.1038/sj.ejcn.1602939. 
Verty, A. N., A. M. Allen, and B. J. Oldfield. 2009. "The effects of rimonabant on brown adipose 
tissue in rat: implications for energy expenditure."  Obesity (Silver Spring) 17 (2):254-61. doi: 
10.1038/oby.2008.509. 
Virtanen, K. A., M. E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi, M. Taittonen, J. Laine, 
N. J. Savisto, S. Enerback, and P. Nuutila. 2009. "Functional brown adipose tissue in healthy 
adults."  N Engl J Med 360 (15):1518-25. doi: 10.1056/NEJMoa0808949. 
Wang, Q. A., C. Tao, R. K. Gupta, and P. E. Scherer. 2013. "Tracking adipogenesis during white 
adipose tissue development, expansion and regeneration."  Nat Med 19 (10):1338-44. doi: 
10.1038/nm.3324. 
Westerterp-Plantenga, M. S., S. G. Lemmens, and K. R. Westerterp. 2012. "Dietary protein - its role in 
satiety, energetics, weight loss and health."  Br J Nutr 108 Suppl 2:S105-12. doi: 
10.1017/s0007114512002589. 
WHO. 2003. "Diet, nutrition and the prevention of chronic diseases."  World Health Organ Tech Rep 
Ser 916:i-viii, 1-149, backcover. 
WHO. 2015. "Obesity and overweight." World Health Organization, Accessed 11.05.15. 
http://www.who.int/mediacentre/factsheets/fs311/en/. 
WHO. 2016. "Commission presents its final report, calling for high-level action to address major 
health challenge." World Health Organization, Accessed 03.16.16. http://www.who.int/end-
childhood-obesity/news/launch-final-report/en/. 
Williams, E. P., M. Mesidor, K. Winters, P. M. Dubbert, and S. B. Wyatt. 2015. "Overweight and 
Obesity: Prevalence, Consequences, and Causes of a Growing Public Health Problem."  Curr 
Obes Rep 4 (3):363-70. doi: 10.1007/s13679-015-0169-4. 
Wu, J., P. Bostrom, L. M. Sparks, L. Ye, J. H. Choi, A. H. Giang, M. Khandekar, K. A. Virtanen, P. 
Nuutila, G. Schaart, K. Huang, H. Tu, W. D. van Marken Lichtenbelt, J. Hoeks, S. Enerback, 
P. Schrauwen, and B. M. Spiegelman. 2012. "Beige adipocytes are a distinct type of 
thermogenic fat cell in mouse and human."  Cell 150 (2):366-76. doi: 
10.1016/j.cell.2012.05.016. 
Wu, J., P. Cohen, and B. M. Spiegelman. 2013. "Adaptive thermogenesis in adipocytes: is beige the 
new brown?"  Genes Dev 27 (3):234-50. doi: 10.1101/gad.211649.112. 
Young, P., J. R. Arch, and M. Ashwell. 1984. "Brown adipose tissue in the parametrial fat pad of the 












Appendix I – Diets 
Table A.1. Diet compositions with analyzed nutrients 
  Casein Chicken Cod Pangasius 
Analyzed      
Energy (kcal/100g) 580 580 570 570 
Fat (g/100g) 24,9 23,7 24 23,8 
Protein (g/100g) 39,8 39,6 40,6 39,5 
Ingredients (g/100g)         
Casein 472     
Cod   482   
Chicken  501    
Pangasius    502 
Sucrose 140 140 140 140 
Fat from protein 
powder* 
2,2 40,0 8,4 31,5 
Corn oil (250g - fat from 
source) 
248 210 242 219 
Dextrin (Potato starch) 40,0 48,2 36,0 38,7 
L-Cysteine 3 3 3 3 
Cellulose 50 50 50 50 
t-Butylhydroquinone 0,01 0,01 0,01 0,01 
Mineral mix † 35 35 35 35 
Vitamin mix ‡ 10 10 10 10 
Choline Bitartrate 2,5 2,5 2,5 2,5 
Total (g) 1000,0 1000,0 1000,0 1000,0 
 















Table A.2 Amino acid composition of the protein sources 
  Casein Chicken* Cod * Pangasius* 
Amino Acid (mg/g)         
Indispensable      
Leucine 85,3 70,4 72,8 76,1 
Isoleucine 43,7 40,7 40,3 43,6 
Valine 59,4 43,9 46,3 46,8 
Lysine 76,4 85,3 93,1 94,6 
Methionine 25,0 24,7 28,3 27,7 
Phenylalanine 44,8 34,9 34,6 38,1 
Threonine 38,0 39,6 39,6 43,1 
Tryptophan 11,0 10,3 9,5 9,9 
Histidine 23,0 23,7 16,9 19,5 
Dispensable      
Alanine 28,0 50,9 54,0 52,7 
Arginine 30,7 53,8 53,7 56,9 
Aspartate 70,6 89,0 101,8 101,0 
Cysteine 0,36 1,02 1 0,95 
Glutamate 213,1 135,2 146,9 148,3 
Glycine 16,2 36,4 38,4 42,3 
Proline 97,7 30,8 30,0 32,8 
Serine 50,8 35,1 39,4 38,5 
Tyrosine 45,9 28,9 30,0 31,5 
Sum BCAA 188,4 155,0 159,3 166,5 
Hydroxyproline 0,0 1,7 1,5 3,6 
Taurine 0,0 0,6 4,8 2,6 
Sum AA 949 824 871 896 






Table A.3 Amino acid composition of the experimental diets 
  Casein Chicken Cod   Pangasius  
Amino Acid (mg/g)         
Indispensable      
Leucine 39,8 32,9 34,0 36,0 
Isoleucine 21,2 19,6 18,7 21,1 
Valine 28,5 21,2 21,5 22,7 
Lysine 35,7 41,0 43,4 45,9 
Methionine 13,3 12,6 14,5 14,0 
Phenylalanine 21,1 15,7 16,1 17,6 
Threonine 17,9 18,4 18,7 20,4 
Tryptophan 4,9 4,9 4,5 5,0 
Histidine 11,1 10,9 8,0 9,2 
Dispensable      
Alanine 13,0 24,1 25,3 25,2 
Arginine 14,7 24,7 25,3 26,8 
Aspartate 32,6 42,7 47,8 48,8 
Cysteine 5 8,4 8,6 8,5 
Glutamate 96,4 64,7 69,4 69,9 
Glycine 7,8 16,6 18,0 19,9 
Proline 45,5 14,1 14,1 15,5 
Serine 24,1 16,3 19,0 18,1 
Tyrosine 20,9 12,7 13,8 14,4 
Sum BCAA 89,5 73,6 74,3 79,8 
Hydroxyproline 0,0 0,0 0,0 1,7 
Taurine 0,00 0,25 2,37 1,23 





Table A.4 Fatty acid composition of the protein sources 
Fatty acids in neutral lipids 
 
  Casein Chicken* Cod * Pangasius* 
Fatty acid (mg/g)         
Sum SFA 0,52 18,10 21,70 20,30 
       
Sum MUFA 0,51 27,20 18,70 19,90 
18:1 (n-9) 0,46 22,57 6,88 18,16 
       
Sum PUFA 0,48 14,10 58,50 8,70 
18:2 (n-6) 0,44 11,75 1,15 5,31 
20:4( n-6) <0,01 0,32 2,09 0,68 
Sum n-6 0,45 12,50 3,86 7,58 
18:3 (n-3) 0,01 1,04 0,26 0,28 
20:5(n-3) <0,01 0,05 17,57 0,06 
22:6 (n-3) <0,01 0,09 33,99 0,21 
Sum n-3 0,04 1,48 54,60 0,83 
       
SUM FA 1,56 60,00 102,00 49,70 
       
n-6/n-3 ratio 12,00 8,40 0,07 9,10 
Fatty acids in phospholipids 
 
  Casein Chicken* Cod * Pangasius* 
Fatty acid (mg/g)         
 Sum SFA 0,09 5,37 2,00 3,14 
       
 Sum MUFA 0,08 4,34 1,28 2,90 
 18:1 (n-9) 0,07 3,38 0,58 2,51 
       
 Sum PUFA 0,06 6,66 4,58 4,77 
 18:2 (n-6) 0,05 2,78 0,09 1,01 
 20:4( n-6) <0,01 1,48 0,13 1,05 
 Sum n-6 0,05 5,06 0,26 3,87 
 18:3 (n-3) <0,01 0,06 0,01 0,03 
 20:5(n-3) <0,01 0,17 0,87 0,04 
 22:6 (n-3) <0,01 0,82 3,24 0,44 
 Sum n-3 0,01 1,56 4,31 0,68 
       
 SUM FA 0,25 18,30 8,02 12,10 
       
 n-6/n-3 ratio 4,83 3,24 0,06 5,67 







Table A.5 Fatty acid composition of the experimental diets 
Fatty acids in neutral lipids  
 
  Casein Chicken Cod  Pangasius 
Fatty acid (mg/g)         
Sum SFA 31,70 32,00 30,70 37,60 
       
Sum MUFA 69,20 66,30 68,10 70,50 
18:1 (n-9) <0,01 62,40 65,42 67,63 
       
Sum PUFA 134 111,00 130,00 113,00 
18:2 (n-6) 131,58 108,40 124,80 111,52 
20:4 (n-6) <0,01 0,12 0,11 0,37 
Sum n-6 132 109,00 125,00 113,00 
18:3 (n-3) 2,02 2,04 2,04 0,03 
20:5 (n-3) <0.,01 0,03 0,95 0,04 
22:6 (n-3) <0.,01 0,04 1,73 0,11 
Sum n-3 2,13 2,28 5,03 0,38 
       
SUM FA 236,00 210,00 229,00 224,00 
       
n-6/n-3 ratio 62,0 47,8 24,9 295,0 
Fatty acids in phospholipids 
 
  Casein Chicken Cod  Pangasius 
Fatty acid (mg/g)         
 Sum SFA 0,29 3,05 1,32 1,78 
       
 Sum MUFA 0,59 2,76 1,28 2,12 
 18:1 (n-9) 0,56 2,17 0,86 1,89 
       
 Sum PUFA 1,09 4,89 3,69 3,62 
 18:2 (n-6) 1,07 2,65 1,08 2,06 
 20:4 (n-6) <0,01 0,81 0,08 0,43 
 Sum n-6 1,07 3,88 1,20 3,22 
 18:3 (n-3) 0,02 0,05 0,03 0,04 
 20:5 (n-3) <0,01 0,13 0,53 0,01 
 22:6 (n-3) <0,01 0,53 1,85 0,18 
 Sum n-3 0,02 0,99 2,49 0,30 
       
 SUM FA 1,97 11,60 6,39 7,97 
       





Appendix II – Histology 
Table A.6 Reagents and time schedule for dehydration upon paraffin embedding 
Reagent Time (min) Vendor 
75% EtOH 45 Arcus Kjemi, Norway 
95% EtOH 45 x 2 Arcus Kjemi, Norway 
100% EtOH 45 x 3 Arcus Kjemi, Norway 
Xylene 45 x 2 Prolabo 
Paraffin overnight Histolab, Sweden 
Paraffin 15 Histolab, Sweden 
 
 
Table A.7 Reagents and time schedule for H&E staining 
Reagent Time Vendor 
Xylene 5 min Prolabo 
100 % EtOH 5 min  Arcus Kjemi, Norway 
95 % EtOH 3 min Arcus Kjemi, Norway 
75 % EtOH 3 min Arcus Kjemi, Norway 
50 % EtOH 3 min Arcus Kjemi, Norway 
ddH2O 2 min MilliQ Biocel, USA 
Hematoxylin 30 sek EMS 
H2O (warm) wash   
Eosin  15 sek Sigma, USA 
H2O wash  
ddH2O 1 min MilliQ Biocel, USA 
50 % EtOH 1 min Arcus Kjemi, Norway 
75 % EtOH 1 min Arcus Kjemi, Norway 
95 % EtOH 1 min Arcus Kjemi, Norway 
100 % EtOH 5 min Arcus Kjemi, Norway 






Appendix III - Immunohistochemistry 
Table A.8 Time schedule for rehydration and rehydration 
Reagent Time Vendor 
Rehydration 
Xylene 15 min Prolabo 
96 % EtOH 15 min Arcus Kjemi, Norway 
75 % EtOH 15 min Arcus Kjemi, Norway 
50 % EtOH 15 min Arcus Kjemi, Norway 
ddH2O 15 min MilliQ Biocel, USA 
Dehydration 
50 % EtOH 5 min Arcus Kjemi, Norway 
75 % EtOH 5 min Arcus Kjemi, Norway 
96 % EtOH 5 min Arcus Kjemi, Norway 
100 % EtOH wash  
 
 
Table A.9 Time schedule and reagents for immunohistochemistry 
Reagent Time Contents and vendor 
Citrate buffer (96 ⁰C) 30 min Tri-sodium citrate dehydrate + ddH2O 
Cool down 20 min  
H2O 2 x 5 min  
3% H2O2 in MetOH 10 min 3 % H2O2 + MetOH (SIGMA) 
1% Tween in PBS 
buffer 
20 min PBS + Technical Tween 20 (VWR) 
PBS buffer 15 min 1000 ml ddH2O + 5 tablets Phosphate Buffered Saline (SIGMA) 
Serum incubation 30 min Vectastain, goat-normal serum (VECTOR laboratories) 
Primary antibody overnight 
Anti UCP1 (C4/98), received from Prof Jan Kopecky and Dr. 
Pavel Flachs 
PBS buffer 30 min  
Secondary antibody 1 hour 
PBS buffer + Vectastain, anti-rabbit IgG antibody (VECTOR 
laboratories) 
PBS buffer 30 min  
ABC 1 hour 
PBS buffer + 2 drops vectastain ABC reagent A + 2 drops 
vectastain ABC reagent B + H2O2 
PBS buffer 30 min  
DAB 7 min 
5 ml ddH2O + 2 drops buffer stock + 4 drops DAB stock solution 
+ 2 drops H2O2 solution 
H2O wash  
Hematoxylin 10 sek EMS 





Appendix IV – Ultra Sensitive Mouse Insulin ELISA Kit 
Table A.10 Reagents in the Ultra Sensitive Mouse Insulin ELISA Kit 
Product Vendor 
Anti-insulin antibody-coated microplate Crystal Chem Inc., USA 
Mouse insulin standard, lyophilised   
Anti-insulin enzyme conjugate stock solution   
Enzyme conjugate diluent   
Enzyme substrate (TMB) solution   
Enzyme reaction stop solution (1 N Sulfuric acid)   
Sample diluent   




Appendix V – RT-qPCR 
Table A.11 Reagents and solutions used in RNA-purification 
Reagent Content Vendor 
Proteinase K Storage Buffer  Beckman Coulter, USA 
Proteinase K soulution Proteinase K + 8,4 ml Proteinase K 
Storage Buffer Beckman Coulter, USA 
Lysis Buffer Solution 600 μl Lysis Buffer + 30 μ Proteinase K  Beckman Coulter, USA 
Binding Buffer (magnetic)  Beckman Coulter, USA 
Wash- and Rebinding Buffer  Beckman Coulter, USA 
70 % EtOH   Arcus Kjemi, Norway 
 
 
Table A.12 RT-reaction mix 
Reagent Volume (μl) Vendor 
ddH2O 890 MilliQ Biocel, USA 
10X TaqMan RT buffer 500 Applied Biosystems 
25 mM MgCl2 1100 Applied Biosystems 
10mM deoxyNTPs Mixture 1000 Applied Biosystems 
50 µM Random hexamer 250 Applied Biosystems 
RNase Inhibitor (20U/µl) 100 Applied Biosystems 







Table A.13 Instrument setup for RT reaction 
Step 
Incubation RT Reverse Transcription 
Inactivation 
End 
HOLD HOLD HOLD HOLD 
Temperature (⁰C) 25 48 95 4 
Time (min) 10 60 5 ∞* 
Volume (μl) 50 
 
 
Table A.14 Primers used for qPCR 
Oligo name Sequence (5' to 3') 
Dgat1 forward GGTGCCATCGTCTGCAAGA  
Dgat1 reverse CCACCAGGATGCCATACTTGA  
Dio2 forward GCCCAGCAAATGTAGAC 
Dio2 rewerse TGGCAATAAGGAGCTAGAA 
Gpd1 forward CTCATCACGACCTGCTATGG 
Gpd1 rewerse CTGCTCAATGGACTTTCCAG 
Gyk forward CAAATGCAAGCAGGACGATG 
Gyk rewerse GGCCCCAGCTTTCATTAGG 
Ppargc1α forward CATTTGATGCACTGACAGATGGA 
Ppargc1α rewerse CCGTCAGGCATGGAGGAA 
Ucp1 forward AGCCGGCTTAATGACTGGAG 

























Figure A.1 Weight of liver, kidneys and m. Tibialis anterior. Weigt of liver (A), kidneys (B) and m. 
Tibialis anterior (C) at termination. All data were analyzed by one-way ANOVA with multiple comparison 
(uncorrected Fisher’s LSD) of the mean of each experimental group. Results are presented as mean ± 
SEM. Statistical differences (p ≤ 0.05) are marked by different letters. 
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